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Abbreviations 
 
 
 
AE                    Acetone extract 
 
AIDS               Acquired immunodeficiency syndrome 
 
BSA                Bovine serum albumin 
 
CLB                  Serum from healthy Dutch person obtained by Central Blood Bank of the  
                        Netherlands 
 
DAT                Direct agglutination test 
 
ELISA            Enzyme-linked immunosorbent assay 
 
FD                    Freeze-dried 
 
HIV                  Human immunodeficiency virus 
 
IFAT                   Indirect Immunofluorescence test  
 
KAtex             Latex agglutination test for urinary antigen detection 
 
LaFT              Lateral flow test 
 
LAT                Latex agglutination test 
 
MQ water       99.9% purified water obtained by Milli Q water system of MILLI  
                                PORE® Company 
 
NC                   Negative control  
 
NM                   Nitrocellulose membrane 
 
OD                  Optical density 
 
PC                    Positive control 
 
PCR                 Polymerase chain reaction 
 
PBS                  Phosphate buffer saline 
 
PKDL             Post kala azar dermal leishmaniasis 
 
SDS-PAGE    Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
 
SIR-2              Silent information regulatory recombinant protien   
 
VL                    Visceral leishmaniasis 
 
 
Abstract 
 
 
Background: Visceral leishmaniasis (VL) represents a major health problem in Sudan 
and other endemic areas. Clinical diagnosis of VL is difficult because the disease shares 
many clinical features with other endemic diseases. There are several diagnostic tools for 
the diagnosis; parasitological, serological and molecular. However, only few tests are 
suitable for the use in the endemic areas that are usually rural and lacking modern 
facilities. Early diagnosis and proper treatment for all VL cases are crucial for disease 
control and hence emerges the importance of developing simple diagnostic tests for the 
field diagnosis. 
 
Objectives: To develop simple, rapid, affordable and accurate test to be used for VL 
diagnosis in the field. Two forms of serological assays; the latex agglutination test (LAT) 
and the lateral flow test (LaFT) were used for development and proof of principle (Phase 
I evaluation  .)  
 
Material and methods: A total of 155 serum samples from confirmed VL patients 
from East Africa and Brazil were used as positive control in the study. More than 300 
serum samples from healthy controls and from patients with other diseases were used as 
negative control. Antigens prepared from Leishmania cultures and one recombinant 
antigen were included in the study. The antigens and their performance were analyzed by 
electrophoresis, ELISA and western blot before being applied on the agglutination and 
lateral flow assays. Three different forms of agglutination assay were tested; using plain 
latex, carboxylated latex and magnetic beads. Both LAT and LaFT underwent many 
several optimization steps before reaching the final test format. 
 
 
Results: Optimal results of LAT based on plain latex were obtained when acetone 
extract of sonicate antigen was used to coat 0.8 µm latex particles in dilution 1:5 and 
blocked with 0.5% skim milk. It gave 95% sensitivity on African VL sera but only 38% 
on the Brazilian ones with over all specificity of 90%. However, blocked latex particles, 
without being coated with Leishmania antigen, were discovered to produce similar results 
leaving many inquiries about the scientific base of the test. LAT based on carboxylated 
latex revealed specificity of 100% but sensitivity of only 57%. Agglutination assay using 
magnetic beads could not be optimized to make good agglutination signals that distinct 
clearly between positive and negative controls. Four models of LaFT were developed and 
evaluated. They revealed sensitivities of 46, 62.5, 91 and 100% and specificities of 100, 
100, 18 and 31% respectively.  
 
Conclusion and Recommendation: None of the developed tests produced satisfactory 
results in the term of sensitivity and specificity and therefore they did not fulfill the 
requirement for Phase I evaluation. More efforts should be spent to find out the more 
suitable Leishmania antigens for rapid diagnostic application. 
 
  
  ﺻﺔاﻟﺨﻼ
 
 
ﻳﻌﺘﺒﺮ . داء اﻟﻠﻴﺸﻤﺎﻧﻴﺎ اﻟﺤﺸﻮي ﻳﻤﺜﻞ ﻣﺸﻜﻠﺔ ﺻﺤﻴﺔ رﺋﻴﺴﻴﺔ ﻓﻲ اﻟﺴﻮدان واﻟﺒﻠﺪان اﻷﺧﺮى اﻟﻠﺘﻲ ﻳﺴﺘﻮﻃﻦ ﻓﻴﻬﺎ :ﺧﻠﻔﻴﺔ
اﻟﺘﺸﺨﻴﺺ اﻟﺴﺮﻳﺮي ﻟﺪاء اﻟﻠﻴﺸﻤﺎﻧﻴﺎ اﻟﺤﺸﻮي ﺻﻌﺒﺎ ﺣﻴﺚ أن هﺬا اﻟﻤﺮض ﻳﺘﺸﺎرك ﻓﻲ أﻋﺮاﺿﻪ وﻋﻼﻣﺎﺗﻪ ﻣﻊ آﺜﻴﺮ ﻣﻦ 
ﻟﻔﺤﻮﺻﺎت اﻟﺘﺸﺨﻴﺼﻴﺔ ﻟﻬﺬا اﻟﺪاء اﻟﻄﻔﻴﻠﻴﺔ ﻣﻨﻬﺎ واﻟﻤﺼﻠﻴﺔ هﻨﺎك اﻟﻌﺪﻳﺪ ﻣﻦ أﻧﻮاع ا. اﻷﻣﺮاض اﻟﻤﺴﺘﻮﻃﻨﺔ اﻷﺧﺮى
ﺑﺮﻏﻢ ذﻟﻚ هﻨﺎك ﻗﻠﺔ ﻓﻘﻂ ﻣﻦ هﺬﻩ اﻟﻔﺤﻮﺻﺎت ﺻﺎﻟﺤﺔ ﻟﻼﺳﺘﺨﺪام ﻓﻲ اﻟﻤﻨﺎﻃﻖ اﻟﺮﻳﻔﻴﺔ اﻟﺒﻌﻴﺪة اﻟﻠﺘﻲ ﻳﺴﺘﻮﻃﻦ . واﻟﺠﺰﻳﺌﻴﺔ
ﻴﺎ اﻟﺘﺸﺨﻴﺺ اﻟﻤﺒﻜﺮ واﻟﻌﻼج اﻟﻤﺘﻜﺎﻣﻞ ﻟﻜﻞ اﻟﻤﺮﺿﻰ اﻟﻤﺼﺎﺑﻴﻦ ﺑﺪاء اﻟﻠﻴﺸﻤﺎﻧ. ﺑﻬﺎ اﻟﻤﺮض وﺗﻔﺘﻘﺪ ﻟﻠﻤﻌﺪات اﻟﺤﺪﻳﺜﺔ
ﻣﻦ هﻨﺎ ﺗﻨﺒﻊ أهﻤﻴﺔ ﺗﻄﻮﻳﺮ وﺳﺎﺋﻞ ﻓﺤﺺ . اﻟﺤﺸﻮﻳﺔ هﻮ أﻣﺮ ﻣﺤﻮري وأﺳﺎﺳﻲ ﻟﻠﺘﺤﻜﻢ واﻟﺴﻴﻄﺮة ﻋﻠﻰ اﻧﺘﺸﺎر اﻟﻤﺮض
  .ﺑﺴﻴﻄﺔ ﻻﺳﺘﻌﻤﺎﻟﻬﺎ ﻓﻲ ﺗﺸﺨﻴﺺ اﻟﻤﺮض ﻓﻲ اﻟﻤﻨﺎﻃﻖ اﻟﺮﻳﻔﻴﺔ اﻟﻠﺘﻲ ﻳﺘﻮﻃﻦ ﺑﻬﺎ
  
ﻴﺸﻤﺎﻧﻴﺎ اﻟﻌﻤﻞ ﻋﻠﻰ ﺗﻄﻮﻳﺮ وﺳﻴﻠﺔ ﻓﺤﺺ ﺑﺴﻴﻄﺔ، ﺳﺮﻳﻌﺔ، زهﻴﺪة اﻟﺜﻤﻦ ودﻗﻴﻘﺔ ﻟﺘﺸﺨﻴﺺ داء اﻟﻠ: أهﺪاف اﻟﺪراﺳﺔ
ﺗﻢ اﺧﺘﻴﺎر ﺷﻜﻠﻴﻦ أﺷﻜﺎل ﻣﻦ اﻟﻔﺤﻮص اﻟﻤﺼﻠﻴﺔ ﻟﻠﻌﻤﻞ ﻋﻠﻰ ﺗﻄﻮﻳﺮهﻤﺎ . اﻟﺤﺸﻮﻳﺔ ﻓﻲ اﻟﻤﻨﺎﻃﻖ اﻟﻨﺎﺋﻴﺔ اﻟﻤﺴﺘﻮﻃﻨﺔ ﺑﻬﺎ
هﺬان اﻟﻔﺤﺼﺎن هﻤﺎ ﻓﺤﺺ ﻣﺘﺮاﺻﺎت اﻟﻼﺗﻜﺲ وﻓﺤﺺ اﻟﺘﺪﻓﻖ (. 1ﻣﺮﺣﻠﺔ ﺗﻘﻴﻴﻢ رﻗﻢ )واﻟﻌﻤﻞ ﻋﻠﻰ إﺛﺒﺎت اﻟﻤﺒﺪأ ﻋﻠﻴﻬﻤﺎ 
  . اﻷﻓﻘﻲ
  
ﻋﻴﻨﺔ ﻣﺼﻞ ﻣﻦ ﻣﺮﺿﻰ ﺛﺎﺑﺘﺔ اﺻﺎﺑﺘﻬﻢ ﺑﺪاء اﻟﻠﻴﺸﻤﺎﻧﻴﺎ اﻟﺤﺸﻮﻳﺔ ﻣﻦ آﻞ  551ﺗﻢ اﺳﺘﻌﻤﺎل ﻣﺎ ﻣﺠﻤﻮﻋﻪ  :ﻣﻨﻬﺠﻴﺔ اﻟﺒﺤﺚ
ﻋﻴﻨﺔ ﻣﺼﻞ ﻣﺄﺧﻮذة ﻣﻦ أﺷﺨﺎص أﺻﺤﺎء  003أآﺜﺮ ﻣﻦ . ﻣﻦ ﺷﺮق اﻓﺮﻳﻘﻴﺎ واﻟﺒﺮازﻳﻞ ﻟﻠﺘﺤﻜﻢ اﻟﻤﻮﺟﺐ ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ
اﺳﺘﻌﻤﻞ ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ ﻣﺴﺘﺎﺿﺎدات أﻋﺪت ﻣﻦ . وﻣﻦ ﻣﺮﺿﻰ ﻣﺼﺎﺑﻴﻦ ﺑﺄﻣﺮاض أﺧﺮى اﺳﺘﻌﻤﻠﺖ آﻤﺘﺤﻜﻤﺎت ﺳﺎﻟﺒﺔ
هﺬﻩ اﻟﻤﺴﺘﻀﺎدات ﺗﻢ ﺗﺤﻠﻴﻠﻬﺎ وﺗﺤﻠﻴﻞ أداﺋﻬﺎ ﺑﻮاﺳﻄﺔ . إﻟﻰ ﻣﺴﺘﻀﺪ واﺣﺪ ﻣﺆﺗﻠﻒ ﺔﺘﺰراﻋﺎت اﻟﻠﻴﺸﻤﺎﻧﻴﺎ ﺑﺎﻻﺿﺎﻓﻣﺴ
ﺗﻢ  .ﻣﺘﺮاﺻﺎت اﻟﻼﺗﻜﺲ واﻟﺘﺪﻓﻖ اﻷﻓﻘﻲ ﻜﻬﺮﺑﻲ واﻹﻟﻴﺰا واﻟﻠﻄﺦ اﻟﻐﺮﺑﻲ ﻗﺒﻞ أن ﻳﺘﻢ ﺗﻄﺒﻴﻘﻬﺎ ﻋﻠﻰ ﻓﺤﺼﻲاﻟاﻟﺮﺣﻼن 
ﺗﻜﺲ اﻟﻤﻨﺒﺴﻄﺔ وذات ﻣﺠﻤﻮﻋﺔ اﻟﻜﺎرﺑﻮآﺴﻴﻞ اﺧﺘﺒﺎر ﺛﻼﺛﺔ أﻧﻮاع ﻣﻦ ﻓﺤﺺ اﻟﺘﺮاص اﺳﺘﺨﺪﻣﺖ ﻓﻴﻬﺎ ﺟﺰﻳﺌﺎت اﻟﻼ
آﻞ اﻟﻔﺤﻮﺻﺎت اﻟﻤﺮاد ﺗﻄﻮﻳﺮهﺎ ﺧﻀﻌﺖ ﻟﻌﻤﻠﻴﺎت ﺗﺤﺴﻴﻦ آﺜﻴﺮة وﻣﺘﻌﺪدة ﻗﺒﻞ . واﺳﺘﺨﺪﻣﺖ آﺬﻟﻚ اﻟﺨﺮزات اﻟﻤﻐﻨﺎﻃﻴﺴﻴﺔ
  .اﻟﻮﺻﻮل ﻟﺼﻴﻐﺘﻬﺎ اﻟﻨﻬﺎﺋﻴﺔ
  
ﻔﻜﻚ ﻓﺤﺺ اﻟﻼﺗﻜﺲ اﻟﻤﺘﺮاص اﻟﻤﺤﺴﻦ ﺗﻢ اﻟﻮﺻﻮل إﻟﻴﻪ ﺑﺎﺳﺘﺨﺪام ﻣﺴﺘﻀﺪ اﻟﻤﺸﺘﻖ اﻷﺳﻴﺘﻮﻧﻲ ﻟﻠﻤﺴﺘﻀﺪ اﻟﻤ :اﻟﻨﺘﺎﺋﺞ
وﺑﺎﺳﺘﻌﻤﺎل  5:1ﻣﺎﻳﻜﺮون ﺑﺘﺨﻔﻴﻒ ﻗﺪرﻩ  8.0ﺻﻮﺗﻴﺎ اﻟﻠﺬي اﺳﺘﻌﻤﻞ ﻟﻴﻐﻄﻲ ﺟﺰﻳﺌﺎت اﻟﻼﺗﻜﺲ اﻟﻤﻨﺒﺴﻄﺔ ذات اﻟﻘﻄﺮ 
ﻋﻠﻰ اﻷﻣﺼﺎل اﻟﺸﺮق أﻓﺮﻳﻘﻴﺔ ﺑﻴﻨﻤﺎ % 59هﺬا اﻟﻔﺤﺺ أﻋﻄﻰ درﺟﺔ ﺣﺴﺎﺳﻴﺔ ﺗﺒﻠﻎ . ﺣﻠﻴﺐ ﻣﻘﺸﻮد آﻌﺎﻣﻞ إﻏﻼق% 5.0
ﺑﺮﻏﻢ هﺬﻩ اﻟﻨﺘﺎﺋﺞ %. 09ﺻﻴﺔ اﻟﻔﺤﺺ آﺎن ﻣﺠﻤﻮع ﺧﺼﻮ. ﻓﻘﻂ ﻋﻠﻰ اﻷﻣﺼﺎل اﻟﺒﺮازﻳﻠﻴﺔ% 83أﻋﻄﻰ ﺣﺴﺎﺳﻴﺔ ﺗﺒﻠﻎ 
وﺟﺪ أن ﺟﺰﻳﺌﺎت اﻟﻼﺗﻜﺲ اﻟﻤﻨﺒﺴﻄﺔ واﻟﻤﻐﻠﻘﺔ ﻓﻘﻂ ﻣﻦ ﻏﻴﺮ أن ﺗﻐﻄﻰ ﺑﻤﺴﺘﻀﺪات اﻟﻠﻴﺸﻤﺎﻧﻴﺎ آﺎﻧﺖ ﻗﺎدرة ﻋﻠﻰ ﺗﺤﺼﻴﻞ 
ﻓﺤﺺ اﻟﻼﺗﻜﺲ اﻟﻤﺘﺮاص . ﻧﺘﺎﺋﺞ ﻗﺮﻳﺒﺔ ﻣﻦ هﺬﻩ ﻣﻤﺎ ﻳﻄﺮح اﻟﻌﺪﻳﺪ ﻣﻦ اﻟﺘﺴﺎؤﻻت ﺣﻮل اﻷﺳﺎس اﻟﻌﻠﻤﻲ ﻟﻬﺬا اﻟﻔﺤﺺ
% 75وﻟﻜﻦ ﺣﺴﺎﺳﻴﺘﻬﺎ آﺎﻧﺖ % 001ﺲ ذات ﻣﺠﻤﻮﻋﺔ اﻟﻜﺎرﺑﻮآﺴﻴﻞ أﻇﻬﺮت ﺧﺼﻮﺻﻴﺔ ﺗﺒﻠﻎ ﺑﺎﺳﺘﻌﻤﺎل ﺟﺰﻳﺌﺎت اﻟﻼﺗﻜ
ﻓﺤﺺ اﻟﺘﺮاص اﻟﻤﺒﻨﻲ ﻋﻠﻰ اﻟﺨﺮزات اﻟﻤﻐﻨﺎﻃﺒﻴﺴﺔ ﻟﻢ ﻳﻜﻦ ﺑﺎﻹﻣﻜﺎن ﺗﺤﺴﻴﻨﻪ ﻟﻴﻜﻮن ﺑﻤﻘﺪورﻩ اﻧﺘﺎج إﺷﺎرات ﺗﺮاص . ﻓﻘﻂ
اﻟﺘﺪﻓﻖ اﻷﻓﻘﻲ  ﺗﻢ ﺗﻄﻮﻳﺮ أرﺑﻌﺔ ﻧﻤﺎذج ﻣﻦ ﻓﺤﺺ. ﻗﺎدرة ﻋﻠﻰ اﻟﺘﻔﺮﻳﻖ ﺑﻮﺿﻮح ﺑﻴﻦ اﻟﻤﺘﺤﻜﻤﺎت اﻟﻤﻮﺟﺒﺔ واﻟﺴﺎﻟﺒﺔ
ﺑﻴﻨﻤﺎ آﺎﻧﺖ ﺧﺼﻮﺻﻴﺘﻬﺎ ﻋﻠﻰ اﻟﺘﻮاﻟﻲ % 001و% 19، %5.26، %64هﺬﻩ اﻟﻨﻤﺎذج أﻇﻬﺮت ﺣﺴﺎﺳﻴﺔ . وﺗﻘﻴﻴﻤﻬﺎ
  %.13و% 81، %001، %001
  
ﻟﻢ ﻳﺘﻤﻜﻦ أي ﻣﻦ اﻟﻔﺤﻮﺻﺎت اﻟﻤﻄﻮرة ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ ﻣﻦ ﺗﺤﻘﻴﻖ ﻧﺘﺎﺋﺞ ﻣﺮﺿﻴﺔ ﻋﻠﻰ  :اﻻﺳﺘﻨﺘﺎﺟﺎت واﻟﺘﻮﺻﻴﺎت
ﻳﻨﺒﻐﻲ ﺑﺬل . 1ﻟﻢ ﻳﺴﺘﻄﻊ أي ﻣﻨﻬﺎ ﻣﻦ اﻟﻮﻓﺎء ﺑﻤﺘﻄﻠﺒﺎت ﻣﺮﺣﻠﺔ اﻟﺘﻘﻴﻴﻢ رﻗﻢ ﻣﺴﺘﻮى اﻟﺤﺴﺎﺳﻴﺔ واﻟﺨﺼﻮﺻﻴﺔ وﺑﺎﻟﺘﺎﻟﻲ 
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ONE 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction and Literature review 
 
Part one: Leishmania and leishmaniasis  
 
1.1.1. The burden of the disease and the importance of field diagnosis 
 
Although being a deadly parasitic illness, visceral leishmaniasis (VL) is one of the 
neglected tropical diseases. It is responsible for more than 75,000 deaths annually 
(Ashford et al., 1992). VL also has many social and economical drawbacks which make 
proper diagnosis and treatment of this chronic disease important for the community as 
well as the patients.  
 
With 500,000 new cases each year (Guerin et al., 2002), the pool of VL keeps 
enlarging. From a public health point of view, it is necessary for any control measure to 
be able to diagnose and treat all patients and therefore, prevent humans from acting as 
reservoirs for the parasite. The vast majority of the affected populations are settled in 
rural areas which are usually far from central health services.  
 
There is a wide agreement among experts on the importance of having a proper 
diagnostic tool for VL that is suitable for use in the field (Boelaert et al., 2007). Simpler, 
faster and cheaper techniques are needed to replace the more invasive parasitological 
methods used currently. 
 
1.1.2. The Parasite 
 
There are more than 30 species of the genus Leishmania, 20 of them can cause the 3 
various forms of leishmaniasis; cutaneous, mucocutaneous and visceral leishmaniasis    
(Cupolillo et al., 2000). Leishmania exist as flagellated extracellular promastigotes in the 
sandfly vector and as aflagellar obligate intracellular amastigotes within mononuclear 
phagocytes of their vertebrate hosts.  The various species are not distinguishable 
morphologically from one another (Marfurt et al., 2003).  When stained with Giemsa, 
amastigotes appear as round or oval bodies ranging from 2 - 3 in diameter with a well 
defined nucleus and kinetoplast, a rod shaped specialized mitochondrial structure that 
contains extranuclear DNA. The flagellated promastigote form is spindle shaped, 
measuring 10 - 20 in length, not including the length of the flagellum.  As in the 
amastigote form a nucleus and kinetoplast are clearly visible.   
 
The parasite life cycle starts when a female sandfly takes a blood meal from an infected 
host.  Small amounts of blood, lymph and macrophages infected with Leishmania 
amastigotes are ingested (Glew et al., 1988). Once ingested, the amastigotes transform to 
promastigotes in the sandfly. The non infective promastigotes divide and develop into 
infective metacyclic promastigotes. These are formed in the midgut of the sandfly and 
migrate to the proboscis.  When the sandfly bites, the inoculated promastigotes at the site 
of the bite is phagocytosed by macrophages.  After phagocytosis, transformation to 
dividing amastigotes occurs within 24 hours.  Reproduction at all stages of the lifecycle 
was believed to occur by binary fission as no sexual stage had been identified R. 
Recently, many evidences on Leishmania sexual reproduction inside the sandfly have 
been discovered, making the vector as a definitive host of the parasite (Kreutzer et al., 
1994 ; Youssef et al., 1997).   
 
1.1.3. The vector 
 
Leishmania is transmitted by the bite of the phlebotomine sandfly. Of 500 known 
phlebotomine species, only about 30 of them have been positively identified as vectors of 
the disease (Adini et al., 2004). Those infective species belong to two genuses; 
Phlebotomus and Lutzamia. The former is responsible for disease transmission in the old 
world, while the letter is the new world infective vector. 
 
The Sandfly is found throughout the world's inter-tropical and temperate regions. It is 2 
to 3 millimeter-long and only the female sandfly transmits the protozoa, infecting itself 
with the Leishmania parasites contained in the blood it sucks from its human or 
mammalian host in order to obtain the protein necessary to develop its eggs (Oliveira et 
al., 2008). During a period of 4 to 25 days, the parasite continues its development inside 
the sandfly where it undergoes a major transformation (Rosenzweig et al., 2008). When 
the infected female sandfly, and hence infectious, feeds on a fresh source of blood, it 
inoculates its new victim with the parasite, and the transmission cycle is completed.  
 
In its search for blood (usually in the evening and at night), the female sandfly covers a 
radius of a few to several hundred meters around its habitat (Sharma and Singh, 2008). It 
then lays its eggs in the burrows of certain rodents, in the bark of old trees, in ruined 
buildings, in cracks in house walls, in animal shelters and in household rubbish, as it is in 
such environments that the larvae will find the organic matter, heat and humidity which 
are necessary for their development (Lewis, 1971). 
  
1.1.4. Leishmaniasis 
 
There are 3 recognized form of leishmaniasis, visceral, cutaneous and mucocutaneous. 
They differ in the clinical presentation and the causing species while the mode of 
transmission, the life cycle and the vector remain the same (Clos and Krobitsch, 1999). 
The definitive host for the parasite is the sandfly and humans and many other vertebrates 
act as secondary hosts and reservoirs.  
 
Cutaneous leishmaniasis, also known as "Aleppo boil," "Baghdad boil” and "Oriental 
sore", is the most common form of leishmaniasis (Oumeish, 1999). There are about 20 
species of Leishmania that may cause this skin infection. L. major, L. tropica, and L. 
aethiopica species are responsible for the disease in the Old World while in the New 
World, the most common causative agent is L. mexicana. The disease in endemic in 
many parts of the world and most common in Afghanistan, Brazil, Iran, Peru, Saudi 
Arabia and Syria (Klaus and Frankenburg, 1999). Following a bite from an infected 
sandfly, a small red papule appears at the site of the bite about 2 – 8 weeks later.  The 
papule increases in size radially.  The patient then possesses either a hypersensitive 
response or an anergic response. In a hypersensitive response, the papule eventually 
ulcerates, becomes depressed and then eventually heals through scarring.  The patient 
becomes immune from subsequent bites.  In an anergic response, the nodule grows and 
spreads over large areas of skin.  This resembles leprosy (Pearson and Sousa, 1996). 
Mucocutaneous leishmaniasis, also known as "Espundia," and "Leishmaniasis 
americana", is a cutaneous condition which occurs at the site of a fly bite. It is 
characterized by an ulceration of the skin and produces destructive and disfiguring 
lesions of the face. It is most often caused by Leishmania (Viannia) braziliensis, and thus 
its more prevalent in South America, but cases caused by L. aethiopica have also been 
rarely described (Kuru et al., 2007). Mucocutaneous leishmaniasis initially starts like 
cutaneous leishmaniasis but develops into lesions in the mucocutaneous junction of the 
pharynx resulting in the break down of the palate of the mouth and nose or more rarely 
the genitalia or anus.  This occurs from a few weeks to several years after the cutaneous 
lesion has healed.  These lesions result in disfiguring deformities of the nose and mouth 
(Pearson and Sousa, 1996). 
Several diagnostic methods are used to diagnose cutaneous and mucocutaneous 
leishmaniasis. Direct detection of the parasite in the lesions is the common one. Many 
other serological and molecular tools are available (Blum et al., 1994). The treatment 
depends mainly on anti-Leishmania antimony compounds. 
1.1.5. Visceral leishmaniasis (VL) 
 
1.1.5.1. A brief history  
 
In Africa and India, reports in the mid-18th century describe the disease now known as 
visceral leishmaniasis. Indian physicians applied the term kala-azar (meaning "black 
fever") because of skin hyperpigmentation which takes place in VL patients (Sundar et 
al., 1997). The disease became known as Leishmaniasis after William Leishman, a doctor 
from Glasgow, Scotland serving with the British Army in India, developed one of the 
earliest stains of Leishmania in 1901. In Dum Dum, a town near Calcutta, Leishman 
discovered ovoid bodies in the spleen of a British soldier who was experiencing bouts of 
fever, anemia, muscular atrophy and swelling of the spleen. Leishman described this 
illness as “dum dum fever” and published his findings in 1903. Charles Donovan also 
recognized these symptoms in other kala-azar patients and published his discovery a few 
weeks after Leishman (Dutta, 2008). After examining the parasite using Leishman's stain, 
these amastigotes were known as Leishman-Donovan bodies and officially, this species 
became known as, Leishmania donovani. By linking this protozoan with kal-azar, 
Leishman and Donovan discovered the genus, Leishmania.  
 
1.1.5.2. Species  
 
Several species of Leishmania are known to give rise to the visceral form of the disease. 
The "Old World" (Africa, Asia and Europe) species are L. donovani and L. infantum 
while the "New World" (South and Central America) species is L. chagasi. Many 
scientists now believe that last two species are in fact one species (Mauricio et al., 1999). 
 
1.1.5.3. Epidemiology  
 
Visceral leishmaniasis is endemic in 62 countries, with a total of 200 million people at 
risk, an estimated 500,000 new cases each year worldwide, and 41,000 recorded deaths in 
the year 2000 (Górski and Wiercińska-Drapało, 2009).  It carries a high mortality rate 
ranging from 80% to 100% if not treated (Ahluwalia et al., 2003).   
 
As is the case for other tropical diseases, epidemiological data are incomplete, and 
official figures are likely to underestimate grossly the real prevalence of the disease. In 
the past two decades, VL incidence rate kept increasing and, furthermore, the disease 
spreads to new geographical areas (Guerin et al., 2002). Over 90% of cases of VL occur 
in five countries: India, Bangladesh, Nepal, Sudan, and Brazil (Murray, 2004). The first 3 
countries of the Indian subcontinent account for 60% of all VL cases (Abdus Salam et al., 
2009). The main causes for the continuous spread of the disease may be related to 
population displacement as a result of war, drought, famine, or rural-urban migration 
(Thakur, 2000). 
 
 For every clinically overt case of VL, there are 30–100 subclinical infections (Ho et 
al., 1982), the potency of the diseases depends on the immunity of the host. Risk factors 
for development of clinical disease include malnutrition and immunosuppressive drugs. 
Malnutrition was found to be associated with 8.7 times higher risk for VL (Cerf et al., 
1987). Over the last twenty years, human immunodeficiency virus (HIV) co-infection 
became the most important single factor for VL contraction (Alvar et al., 1997). Cases of 
co infection are seen as an imported disease in non-endemic areas like Italy, Spain and 
Portugal (Pintado et al., 2001). About two cases are seen each year in the United 
Kingdom, and these usually originate from around the Mediterranean (Lockwood, 2006). 
Leishmania-HIV co-infections are difficult to diagnose, respond poorly to treatment and 
relapse repeatedly (Medrano et al., 1998). 
 
Visceral leishmaniasis has negative socio-economic drawbacks as the disease attacks 
older children and young adults (Guerin et al., 2002). Transmission is mostly domestic, 
but the male preponderance suggests an occupational association with deforestation, 
agriculture and cattle grazing mainly (Wijeyaratne et al., 1994). Immigrating seasonal 
workers to endemic regions are particularly vulnerable to disease since they have no 
innate immunity (Bora, 1999). 
 
1.1.5.4. Clinical features 
 
1.1.5.4.1. Incubation Period 
 
The incubation period is highly variable. In most cases it appears to be between 2 and 6 
months, but it may vary within much wider limits (anytime between ten days to over one 
year) (Kirk, 1939). Intensity of infection depends mainly of the immunity status of the 
host. In non-immune individuals, who become infected while travelling in endemic areas, 
the disease appears to run a more acute course than in individuals who live in endemic 
areas (Hashim et al., 1994). Intercurrent illness, like Leishmania-HIV co-infection, and 
malnutrition lead to more severe form of the disease.   
 
1.1.5.4.2. Symptoms 
 
The most important symptom is fever. Virtually it occurs in all patients. It is described 
as high undulating fever often with two or even three peaks in 24 hours associated with 
chills, rigor and drenching sweats (Kumari and Ram, 2002). Weight loss is the second 
classical symptom. However, anorexia is not constant since some studies reported good 
appetite (Mengistu and Ayele, 2007).  Epistaxis is also common in VL patients. Although 
it may be a result to thrombocytopenia, some studies on canine VL suggested direct 
parasite effect on nasal vessels and mucosa (Jüttner et al., 2001). Abdominal symptoms 
like abdominal pain, nausea and diarrhea may also present. Other less common symptoms 
include headache, insomnia, cough, joint pain, burning sensation and skin change. 
Constitutional symptoms like fatigability and malaise are the mainstay of the disease 
(Kumari and Ram, 2002). 
 
1.1.5.4.3. Signs 
 
Splenomegaly is the most important clinical sign and it presents in more than 95% of 
VL patients (Sundar et al., 1998). VL is known to cause gross enlargement of the spleen 
as it acts as parasite reservoir (Veress et al., 1977). In most patients, the spleen regress to 
its normal size after cure. Hepatomegaly also does occur but is not as common as 
splenomegaly. Lymphadenopathy is an important sign of VL patient from Sudan but not 
seen in other VL endemic areas like India and Brazil (Aleixo et al., 2006). This lymph 
nodes enlargement provides good diagnostic tool as fine needle aspiration of enlarged 
inguinal lymph nodes is quite simpler and more convenient than bone marrow aspiration 
(Sah et al., 2005). Less common signs include jaundice and oedema. Both neurological 
and psychiatric signs are also reported but quite rare (Prasad and Sen, 1996).   
 
1.1.5.4.4. Post Kala-azar Dermal Leishmaniasis (PKDL) 
 
It is a dermatosis that usually occurs after VL caused by Leishmania donovani and 
characterized by macular, maculo-papular, and nodular skin lesions on the whole body 
surface (Das et al., 2009).  
 
PKDL is frequent in India and the Sudan while it is rarely reported in South America 
(Bittencourt et al., 2002). In India PKDL occurs in 6% to 20% of the cases of visceral 
leishmaniasis (VL), six months to five years after apparently successful treatment of VL 
(Singh et al., 1998). In Africa PKDL is a common complication of VL, occurring in 57% 
of the cases. However, a significantly higher PKDL rate (69%) is observed in those 
patients who received inadequate or irregular treatment. African PKDL appears during or 
shortly after treatment (Zijlstra et al., 2000). This type of skin lesion of PKDL may 
develop from asymptomatic cases of VL where no kala-azar development occurs but who 
had infection in the past. Previously, very few cases have been reported in which PKDL 
and VL has been associated. Cases of PKDL are of considerable epidemiologic 
importance, because these act as reservoirs of parasites. Transmission of parasite from 
PKDL cases to other individuals by sandflies may have been responsible of many 
outbreaks in several parts of the world including massive epidemic of kala-azar in Bihar, 
India in the 1970s (Das et al., 2009). As for VL, poverty, overcrowding, malnutrition, 
illiteracy, and poor domestic conditions facilitate the growth of this disease, which is 
represents a major health problem of endemic kala-azar region in India (Ranjan et al., 
2005). 
 
1.1.5.4.5. Clinical diagnosis 
 
Clinical diagnosis must be confirmed by laboratory diagnosis since many diseases, 
especially tropical diseases, share similar symptoms and signs. The Differential diagnoses 
should also consider malaria, enteric fever, schistosomiasis, African trypanosomiasis, 
Chagas' disease, haemoglobinoathies (especially sickle cell anaemia), malnutrition, 
tuberculosis, brucellosis, hyper-reactive malarial splenomegaly (formerly known as 
Tropical Splenomegaly Syndrome) and acquired immunodeficiency syndrome (AIDS) 
(De Gorgolas and Miles,1994 ; Chappuis et al., 2007). 
 
1.1.5.5. Laboratory diagnosis 
 
Laboratory diagnosis can be divided to parasitological, histological, serological and 
DNA detection based methods: 
  
1.1.5.5.1 Parasitological diagnosis: 
 
1.1.5.5.1.1. Direct microscopy: 
The accepted gold standard for the diagnosis of VL is the demonstration of the 
leishmanial amastigote by direct microscopy in stained smears from lymph node, bone 
marrow or splenic aspirate (Abdel-Hameed, 1993). The presence of the parasite can also 
be demonstrated in liver biopsy or aspirate specimens and also the buffy coat of 
peripheral blood in some VL patients (Shamsuzzaman et al., 2007). Amastigotes appear 
as round or oval bodies measuring 2 to 3 µm in length and are found intracellularly in 
monocytes and macrophages. In preparations stained with Giemsa or Leishman stain, the 
cytoplasm appears pale blue, with a relatively large nucleus that stains red. In the same 
plane as the nucleus, but at a right angle to it, is a deep red or violet rod-like body called a 
kinetoplast (Sundar and Rai, 2002). After identification, parasite density can be scored 
microscopically by means of a logarithmic scale ranging from 0 (no parasite per 1,000 oil 
immersion fields) to +6 (>100 parasites per field) (Chulay and Bryceson, 1983). The 
sensitivity of the bone marrow smear is about 60 to 85% (da Silva et al., 2005; Boelaert 
et al., 2007).  
 
Splenic aspirate, though associated with risk of fatal hemorrhage in inexperienced 
hands, is one of the most valuable methods for diagnosis of kala-azar, with a sensitivity 
exceeding 95% (Sundar and Rai, 2002). It requires no special equipment and quite less 
painful than bone marrow aspiration but needs a highly experienced hands. Splenic 
aspirate can be performed even when spleen is not palpable, after demarcating the area of 
splenic dullness by percussion (Abdel Hameed, 1993). The only risk of splenic puncture 
is bleeding from a soft and enlarged spleen. Direct microscopy on lymph node aspirate is 
common in Sudan, where generalized lymphadenopathy is a recognized feature of VL 
patients, but infrequent in other endemic areas. Sah et al. (2005) demonstrated 
amastigotes in 19 out of 21 VL patients with lymphadenopathy in Nepal. In the 
Mediterranean region, diagnosis of VL by lymph node aspiration was reported in few 
cases in Tunisia (Aoun et al., 2002) and Spain (Reus et al., 2005). 
 
Although demonstration of even a single amastigote upon microscopic examination of 
tissue smears or multiple promastigotes in cultures is considered sufficient for positive 
diagnosis of the disease, the sensitivity of the tissue examination, except in the case of 
splenic aspirate, is low. Moreover, the procedures for obtaining tissue specimens are 
traumatic and associated with considerable risk. Identification of amastigotes requires 
considerable expertise and training and is subject to the ability of the observer. 
 
1.1.5.5.1.2. In vitro culture: 
Although culture of parasite can improve the sensitivity of detection of parasite, 
leishmania culture is rarely needed in routine clinical practice because of being 
expensive, time consuming and requires expertise and costly equipment (Singh and 
Sivakumar, 2003). However, there are many situations where cultures are required: (i) 
obtaining a sufficient number of organisms to use an antigen for immunologic diagnosis 
and speciation, (ii) obtaining parasites to be used in inoculating susceptible experimental 
animals, (iii) in vitro screening of drugs, and (iv) accurate diagnosis of the infection with 
the organism, either as a supplement to other methods or to provide a diagnosis when 
routine methods have failed (Sundar and Rai, 2002).  
 
Leishmania strains can be maintained as promastigotes in artificial culture medium. 
The culture media used may be monophasic like Schneider's insect medium, M199, or 
Grace's medium or diphasic  as Novy-McNeal Nicolle (NNN) medium and Tobies 
medium (Ihalamulla et al., 2005). Hockmeyer's medium, which is Schneider's 
commercially prepared culture medium supplemented with 30% heat-inactivated fetal 
calf serum with 100 IU of penicillin and 100 µg of streptomycin, is simple to use and 
satisfactory for diagnosis of VL, but it is expensive (Hockmeyer et al., 1981). Culture 
tubes are inoculated with 1 to 2 drops of bone marrow or splenic aspirate and incubated at 
a temperature between 22 and 28°C. The tubes are examined weekly for the presence of 
promastigotes by phase-contrast microscopy or by wet mount of culture fluid for 4 weeks 
before being discarded as negative (Sundar and Rai, 2002). If promastigotes are present, 
they are maintained by weekly passage to fresh medium. Blood can also be used to 
isolate the parasite, but the method is slow and takes longer. Contamination of the culture 
media by bacteria or yeast species or other fungi usually complicates the culture but can 
be avoided by use of good sterile techniques and by the addition of penicillin (200 IU/ml) 
and streptomycin (200 µg/ml) to the medium (for bacteria), as well as 5-flucytosine (500 
µg/ml) (as an antimycotic agent) (Schur and Jacobson, 1987). 
 
1.1.5.5.1.3. Animal inoculation: 
The parasite can also be demonstrated after inoculation of laboratory animals (such as 
hamsters, mice or guinea pigs) with infected specimen (Marsden, 1986). Animal 
inoculation is not usually employed as a diagnostic test, since several months may be 
required to obtain a positive result. Golden hamster is the animal of choice for 
maintaining L. donovani complex (Bray, 1987). It can be infected via many routes, 
including across mucous membranes, but intraperitoneal and intrasplenic routes are 
preferred. Both amastigotes and promastigotes can infect the animal. After inoculation, 
the animal is examined weekly for signs of infection, such as cutaneous lesions, 
hepatosplenomegaly, or metastatic lesions. Amastigotes can be harvested by biopsy from 
the spleen and the liver of an animal that is under anesthesia and that is allowed to 
survive following the procedure as a source of infective parasite. In the absence of signs 
of obvious infection, the animal is generally sacrificed after 4 months, at which point 
liver and spleen samples are examined for the presence of the parasite (Sundar and Rai, 
2002). 
 
 
1.1.5.5.2 Tissue histology: 
 
The parasite can be demonstrated in various tissue specimens from spleen, liver (Duarte 
et al., 1989) or lymph node. These specimens are subjected to imprint cytology by the 
repeated pressing of its cut flat surface on microscopic slides. The smear is fixed with 
absolute alcohol and stained with Giemsa stain. In imprint cytology, a monolayer of cells 
is formed and amastigotes are easily identifiable. The results are expressed as the number 
of leishmania per 100 host cell nuclei (Sundar and Rai, 2002).. Tissue specimens can also 
be subjected to histology, and the presence of parasites can be demonstrated by standard 
hematoxylin and eosin stain (Zijlstra and El Hassan, 2001). They are usually uneven in 
thickness; consequently the amastigotes are unevenly distributed. Long searches may be 
required to demonstrate the parasite. The sensitivity of the test can be increased by 
staining the specimen with fluorescent dye-tagged antibodies to the surface receptors of 
the parasite (Sundar and Rai, 2002). Fluorescein isothiocyanate isomer- or rhodamide B 
isothiocyanate-conjugated antiserum is usually used for this purpose (Eldaw and Khalfan, 
1988). Fluorescent dye-conjugated monoclonal antibodies are also used for speciation of 
the parasite. Indirect immunoperoxidase technique has also been used to enhance 
identification of Leishmania parasite in several kinds of tissue smears (Livni et al., 1983). 
 
 
1.1.5.5.3. DNA detection method: 
 
1.1.5.5.3.1. Overview 
Due to the limitations inherent in techniques used for detection of parasites by direct 
microscopy or in vitro culture, new approaches to the detection of parasites by  DNA 
hybridization, have been attempted since the early 1980s (Barker and Butcher, 1983 ; 
Sundar and Rai, 2002). Although these methods had considerable sensitivity, their 
potential use in routine diagnosis is hampered by the complex procedure of hybridization 
(Wirth et al., 1989). The development of Polymerase Chain Reaction (PCR) has provided 
a powerful approach to the application of molecular biology techniques to the diagnosis 
of leishmaniasis. Besides being a highly sensitive and specific tool for diagnosis of both 
VL and PKDL and a useful method for species identification (Minodier et al., 1997), 
PCR can also be used to distinguish between relapse and reinfection in treated VL 
patients. It could also prove to be an important tool in assessing the success of VL 
treatment (Sundar and Rai, 2002). In one study, none of patients treated for VL who 
tested negative by PCR with lymph node tissue relapsed or developed PKDL, while more 
than half of patients who tested positive by PCR with lymph node tissue either relapsed 
or developed PKDL after apparent cure of disease following supervised treatment 
(Osman et al. 1997a ; Osman et al 1998). On the other hand, a substantial number of the 
patients who tested positive by PCR, after apparent cure, did not relapse or develop 
PKDL, a result that suggests the limitation of PCR in deciding the end point of treatment 
(Sundar and Rai, 2002). The PCR positivity observed in these patients may be due to 
nonviable parasite. Similarly, PCR results for healthy endemic controls may be positive 
(Le Fichoux et al. 1999), which may lead to the erroneous conclusion that they suffer 
from VL. In these healthy endemic controls, a combination of direct agglutination test 
(DAT) (which shows high titers in healthy endemic controls and PCR may be helpful in 
defining the status of these patients (Sundar and Rai, 2002). 
 
1.1.5.5.3.2. Conventional PCR 
In recent years, PCR-based diagnostic methods with a wide range of sensitivities and 
specificities have been described (Adhya et al., 1995 ; Andresen et al., 1997). In one 
study from India, a species-specific primer for L. donovani was used in PCR performed 
on whole blood from VL patients. It gave sensitivity of 96% (Piarroux et al., 1994). 
Fissore et al. (2004) evaluated PCR on serum samples from 33 parasitologically 
confirmed VL patients and 22 negative controls. They reported sensitivity of 97% and 
specificity of 95% with positive and negative predictive values of 94% and 97% 
respectively. PCR done from blood spots on filter paper can also be used as a screening 
test to identify Leishmania infection in immunocompromised patients with high parasite 
loads in peripheral blood. The sensitivity of this technique for detecting leishmania (75%) 
was considerably higher than the respective sensitivities of microscopy (26.3%) and 
blood culture (42.3%) (Campino et al., 2000). However, PCR assay with buffy coat 
preparations to detect Leishmania was 10 times more sensitive than that with whole-
blood preparations (Lachaud et al., 2001). 
 
1.1.5.5.3.3 Specific PCR 
 
1.1.5.5.3.3.1 PCR-ELISA 
A PCR-enzyme-linked immunosorbent assay (ELISA) technique has been developed 
recently (Martin-Sanchez et al., 2001). In this assay, PCR is followed by hybridization of 
PCR products to an immobilized labeled probe in microtiter plates. The detection is 
similar to ELISA.  
This technique reported sensitivity higher than that of indirect fluorescent-antibody test, 
parasite culture, or microscopy. It was able to detect a minimum of 0.1 promastigote or 1 
fg of genomic material. In one comparative study, PCR-ELISA was found more sensitive 
(84%) and specific (100%) when compared to conventional PCR (73% and 87%) (De 
Doncker et al., 2005). This technique can potentially be used for diagnosis of VL from 
peripheral blood samples (Martin-Sanchez et al., 2001). 
 
1.1.5.5.3.3.2 Fluorescent PCR 
This technique uses fluorescent DNA probe specific for a conserved region of the small 
subunit rRNA gene of Leishmania.  Using this probe with a pair of flanking primers, 
results in DNA amplification that proved to be a highly specific and rapid diagnostic 
modality to detect infection with Leishmania (Wortmann et al., 2001). DNA from 27 
strains of cultured Leishmania was amplified successfully with this rapid fluorogenic 
PCR technique. It was also used to amplify Leishmania DNA from fresh human tissue 
biopsy and the turnaround time to test result was found to be less than 24 h (Wortmann et 
al., 2001). 
 
1.1.5.5.3.3.3 RFLP-PCR 
Restriction fragment length polymorphism (RFLP) analysis of the PCR-amplified 
minicircle of leishmanial DNA is utilized mainly for Leishmania species identification 
(Morales et al., 2001). In this technique, the amplicon is treated with a restriction 
endonuclease following PCR. If the recognition site for this enzyme is present in the 
amplicon, two or more restriction fragments are generated. Thus sequence variation 
between individuals at the recognition site(s) can be detected by electrophoresis 
(Pourzand and Cerutti, 1993). 
Recently, PCR-RFLP method was found to be reliable, fast and having potential value 
for the diagnosis and identification of Leishmania in clinical specimens, infected 
reservoirs and vectors (Volpini et al., 2004). 
 
1.1.5.5.3.3.4 Real-Time PCR 
Real-Time PCR is a laboratory technique based on the PCR, which is used to amplify 
and simultaneously quantify a targeted DNA molecule (Bretagne et al., 2001). It enables 
both detection and quantification, of one or more specific sequences in a DNA sample, as 
absolute number of copies or relative amount when normalized to DNA input. Real-Time 
PCR was found to be reliable, rapid method for the diagnosis of VL. In addition, it might 
also be of value in monitoring the response to antileishmanial treatment and as an early, 
preclinical, prognostic marker of relapse (Bossolasco et al., 2003). The fact of being 
expensive and complicated makes it unsuitable for field diagnosis 
 
 
1.1.5.5.4 Serology: 
 
1.1.5.5.4.1. Overview 
Serological tests are based on antigen-antibody reactions. Many serological tests were 
developed for the diagnosis of VL. Old tests were non-specific and aimed to detect high 
levels of immunoglobulin found in VL, e.g. Formal Gel Test and Antimony Test (Chopra 
test) (Abdalla, 1980). They have poor sensitivity and specificity and should no longer be 
used (Hommel et al., 1997). Countercurrent immunoelectrophoresis (CIEP), complement 
fixation and indirect haemagglutination test also have been largely superseded by newer 
tests with better accuracy (Boelaert et al., 2007). 
 
Serodiagnostic methods are of immense importance in the detection of VL cases and 
epidemiological survey of the disease. These different techniques use whole parasite, its 
cell-free extracts, and its different antigenic fraction or purified antigens for the purpose 
of antibodies detection (Kar, 1995). The performance of the tests is dependent on the 
antigen specificity to reduce the cross-reaction with cross-reacting diseases such as 
African trypanosomiasis, Chagas' disease, leprosy, tuberculosis, malaria, etc. and to 
reduce the false positive reaction with a normal human, particularly endemic origin 
(Boelaert et al., 2007). The detection of antibody reaction should be evaluated 
simultaneously with the clinical picture and, if necessary, other supported investigation 
for conclusive diagnosis of VL. In active VL, tests for antibody are always positive. The 
majority of serological techniques are convenient to use in field conditions and 
epidemiological surveys of the disease (Kar, 1995). 
 
1.1.5.5.2. Indirect Immunofluorescence test (IFAT): 
This technique involves formation of an antigen-antibody complex which is labeled 
with fluorescein-conjugated anti-immunoglobulin antibody (Badaro et al., 1983). The 
application of this test is limited because it requires an immunoflorescent microscope and 
is therefore unsuitable for use in the field (Mittal et al., 1991). The test is sensitive as 
many studies reported 100% sensitivity comparing to direct microscopy (Badaro et al., 
1983). However it has low specificity in its lowest, most sensitive titers. In one study, the 
sensitivity of the IFAT test was 100% and specificity was 52% and 72%, at dilutions of 
1:20 and 1:40, respectively (Abramo et al., 1995). At a dilution of 1:80, the sensitivity 
was 86% and the specificity was 90% in the same study. Thus, the choice of the final 
dilution of serum for use for the diagnosis of VL should take into account the study 
population and the type of parasites prevalent in the area (Sundar and Rai, 2002). Another 
major disadvantage is its cross-reaction with many other tropical diseases (Abramo et al., 
1995).  IFAT has been widely superseded by newer serological tests, e.g. DAT, which are 
simpler and more accurate (Boelaert et al., 2007). 
 
1.1.5.5.3. Enzyme-linked Immunosorbent Assay (ELISA) 
Enzyme-linked immunosorbent assay (ELISA) techniques have proven to be useful VL 
diagnostic tool. Since the original efforts of Hommel et al. 1976, there have been a 
number of reports on serological detection of VL-specific antibodies using a variety of 
antigens (Maalej et al., 2003). Most of the earlier works performed on lysate (soluble) 
antigen lacked specificity and gave considerable amount of false positives (Kar, 1995). 
On the other hand, sub-unit antigens showed limited scope for active phase of infection 
(Raj et al., 1999). Antibody ELISA for VL requires highly specific antigen as the starter 
reagent in order to capture specific antibody. In the last few years, an increasing number 
of Leishmania antigens have been characterized. Some of these antigens are considered 
to be species specific proteins such as surface protease gp63, surface glycoproteins gp46 
and the lipophosphoglycan associated proteins: KMP 11, kinesin, heat shock protein, 
acting and tubulin (Soto et al., 1998). However, their utility as clinical and 
epidemiological tools is yet to be determined. Considerable amount of effort is being put 
to develop appropriate ELISA for field use (Rajasekariah et al., 2001). Prime examples in 
this direction include the rK39 (Shreffler et al., 1993;  Badaro et al., 1996) , gp63 
(Okong’o-Odera et al., 1995), B recombinant product (Jensen et al., 1999) and MAb D2 
(Chatterjee et al., 1999). 
 
In recent years, rK39 became preferable over the conventional soluble antigen (Abdus 
Salam et al., 2009).  Antibodies to rK39 antigen could be detected by enzyme-linked 
immunosorbent assay (ELISA) in nearly 98% of sera from patients with visceral 
leishmaniasis in Brazil (Burns et al., 1993) and China and Pakistan (Qu et al., 1994). In 
addition, antibody titers were found to correlate with parasite burden and may be useful 
in evaluating the result of chemotherapy (Singh et al., 1995). Recently, it was suggested 
that the presence or absence of antibodies to rK39 may predict progression to VL or self-
healing, respectively (Badaro et al., 1996). rK39 ELISA titers remain positive for up to 2 
years after treatment (Singh et al., 2002). 
 
1.1.5.5.4. Direct Agglutination Test (DAT) 
The DAT for VL was first described by Allain and Kagan (1975). El Harith and others 
adapted the method and recommended the DAT for clinical work in hospitals and health 
centers (El Harith et al., 1986), for mass VL population screening (El Harith et al., 1987) 
and for seroepidemiologic studies (El Harith et al., 1988). They used whole, stained 
promastigotes in aqueous suspension as antigen. Further improvement in the test had 
been achieved through changing its liquid antigen, which is of limited stability, into 
freeze-dried (FD) format (Meredith et al., 1995). By using the FD antigen, logistic 
problems, such as the need of a cold chain for storage of antigen, are avoided, making the 
DAT very suitable for use under field conditions (Oskam et al., 1999). 
 
The DAT has proved to be a very important serodiagnostic tool combining high levels 
of intrinsic validity and ease of performance (Boelaert et al., 1999a). It is still the first 
line diagnostic tool in many developing countries (Oskam et al., 1999), as it is a simple 
test with high sensitivity, specificity and reproducibility, easy to perform, economical and 
does not require specialized equipment (Silva et al., 2005).  
 
The DAT passed through many developing steps, especially on the level of antigen, to 
reach sensitivity of 96% and specificity of 99% with the FD-DAT at titer ≥ 1:3200 
(Meredith et al., 1995). It has been, constantly, reporting high figures in term of 
sensitivity and specificity in all endemic areas. In Sudan 95.9% & 99.4%, Ethiopia 94.0% 
& 93.6%, Kenya 98.8% & 81.9%, India  98.3% & 91.0%, Nepal  98.5% & 95.4% and 
Brazil 100% & 97.8% (Boelaert et al., 2008 ; Oskam et al., 1999 ; Oliveira et al., 2009) 
 
The DAT still has some limitations like the relative long incubation time (18 hours) and 
the need for serial dilutions of blood or serum. It is also not capable of distinguishing 
between past kala-azar, subclinical infection, and current disease (Zijlstra et al., 1991). It 
is reported that increased levels of anti-Leishmania antibodies may be present for a long 
time after completion of treatment (Hailu, 1990). On the other hand, if VL is associated 
with HIV infection or other sources of immunocompromise, a considerable number of 
patients lack detectable levels of antibodies (Gari-Toussaint et al., 1994). Therefore, as 
with all serodiagnostic tests, the significance of positive or negative results in the DAT 
should always be judged against clinical data and the results of other diagnostic methods 
(Meredith et al., 1995). 
 
1.1.5.5.5. rK39 Dipstick Test 
rK39 is a cloned antigen of 39 amino acids acid repeats of a kinesin like gene found in 
L. chagasi (Burns et al. 1993). Its gene contains a repetitive 117-bp sequence encoding 
this residue which is conserved at the C-terminal end in all of the VL-causing isolates 
examined so far. It has been used as an antigen in ELISA (Zijlstra et al., 1998) and in 
rK39 dipstick test (Sundar et al. 1998). The latter test is of immunocromatographic base 
in strip formats. The test is simple, rapid (10 minutes), requires no other reagents or 
instruments and can be performed in the field by the paramedics (NandLal et al., 2009). 
 
Studies using the rK39 antigen, either in an ELISA or dipstick form, performed well in 
Brazil, India and Europe. Rouf et al. (2009) evaluated the test on 60 confirmed VL 
patients and 60 negative controls. They reported sensitivity of 95% and specificity of 
98.3%. Chappuis et al. (2005) carried out a meta-analysis of 30 studies evaluated rK39 
dipstick test in Southeast Asia. They estimated combined sensitivity and specificity of 
94.8% and 93.9% respectively. In Brazil, sensitivity of 90% and specificity of 100% were 
reported (Carvalho et al., 2003). In another recent study from Tunisia, the sensitivity of 
rK39 dipstick was 87.1% with specificity of 94.4% (Saghrouni et al., 2009). For reasons 
still not well understood, the test did not show good performance in East African endemic 
areas. In one multicentre study, rK39 dipstick test scored sensitivities of 71% in Ethiopia 
and 84.5% in Kenya with specificities of 64% and 87.8% in the two countries 
respectively (Boelaert et al., 2008). 
 
 rK39 dipstick test has many drawbacks. Cross reactivity may occur with malaria, 
enteric fever, disseminated tuberculosis (Sharma et al., 2009). Although the test is 
relatively inexpensive, at least one comparative study found no advantages for the 
diagnosis of VL in endemic areas compared with IFAT. Both tests showed similar 
performances in the diagnosis of VL but with rK39 was of higher cost (Romero et al., 
2009). 
  
Apart from its use in diagnosis of VL, it can reliably be used for early diagnosis and 
planning prophylactic treatment of latent infection in asymptomatic carriers, family 
members, and contacts (Singh et al., 2002). Its utility has also been demonstrated in 
serodiagnosis of both symptomatic and asymptomatic canine leishmaniasis (Mettler et 
al., 2005). Thus, it can be particularly useful in mass screening surveys of both humans 
and animals in targeted control programs (Sharma et al., 2009).  
 
1.1.5.5.6. Latex Agglutination Test for urinary antigen (KAtex) 
A latex agglutination test (Katex) for detection of leishmanial urinary antigen in VL 
patients was developed by Attar et al., in 2001. Several studies have demonstrated 
leishmanial antigen in the urine of VL patients. Sarkari in 2002 detected a 5–20’’ kDa 
carbohydrate-based antigen in the urine of VL patients, which was target of the 
previously designed Katex (Sarkari et al., 2002; Hatam et al., 2009).  
 
Katex is an antigen detection method. Since VL is a chronic infection, the detection of 
antigens in patient serum is complicated by the presence of high levels of antibodies, 
circulating immune complexes, serum amyloid, rheumatoid factors and autoantibodies. 
These problems could, theoretically, be avoided by detecting antigen in the urine 
(Kohanteb et al., 1987). To achieve this, Attar et al., 2001 prepared polyclonal anti-
leishmanial antibodies and then used to coat latex beads. Then the test was performed by 
mixing latex with patients’ urine on agglutination card.  
 
Evaluation of Katex showed 100% specificity and 68–100% sensitivity using urine 
collected from confirmed cases and controls from Brazil, Yemen, and Nepal (Sarkari et 
al., 2002). Other studies reported different sensitivities and specificities for Katex, 
including: 67 and 99% in India, 57 and above 90% and 47.7 and 98.7% (Rijal et al., 
2004) in two studies in Nepal, 73.9 and 82.4% in Ethiopia (Diro et al., 2007), and 82.7 
and 98.9% in Iran  (Malaei et al., 2006).  
 
The Katex had been used in one study for diagnosis of VL in 49 Leishmania-HIV co-
infected patients and a sensitivity of 85.7% was reported (Riera et al., 2004). The 
conclusion was made that Katex is an appropriate method for primary diagnosis and 
monitoring the efficacy of treatment in Leishmania-HIV coinfected cases (Sunder et al., 
2005). Recently in two studies from Spain in 49 and 12 patients coinfected with HIV and 
VL, the sensitivity of KAtex was 85.7% and 100%, respectively, and the specificity in 
one of these studies was 96% (Vilaplana et al., 2004; Riera et al., 2004). However, in 
another study from Nepal in large number of patients, the sensitivity was low (47.7%), 
although the specificity was high (98.7%) (Rijal et al., 2004).   
 
This test is useful in difficult field conditions because it is simple, easy to perform, does 
not require any equipment, can be performed at the patient’s bedside and is read visually. 
It is also quick and the result can be read within few minutes (Riera et al., 2004). The use 
of urine over other conventional samples taken for VL diagnosis offers an advantage in 
that urine is easy to obtain. The test kit is commercially available from the manufacturer 
at a price of US $1.8 per test, which is slightly higher than rK39 strips (1.2–1.5 US $) 
(Sunder et al., 2005). One of its best advantages is that Katex has the ability of 
discriminating between active and past infections, predictive of response to treatment. At 
the end of treatment it correlates well with the negative splenic parasite status. Its 
correlation with active VL makes it superior to other diagnostic tests that use body fluids 
(Sundar et al., 2005). It is also superior over other serological antibodies-detecting tests 
(e.g. DAT) for VL diagnosis in Leishmania-HIV coinfected patients (Riera et al., 2004). 
 
The disadvantages of the KAtex test include the requirement that the kit be stored at 
4°C and its availability as a kit only for a minimum 100 tests. The need to boil the urine 
in field conditions for the Katex test can also be difficult (Sundar et al., 2005). In fact, 
one of the main drawbacks of the test is that the samples need to be boiled for 5 minutes 
to remove the false-positive reactivity in some of healthy individuals. Boiling may 
decline field applicability of the test. Furthermore, inconvenient odor of urine during 
boiling process in closed spaces like laboratory is usually a subject of complaint by those 
who are performing the test (Hatam et al., 2009) 
 
1.1.5.5.7. Latex Agglutination test (LAT) 
The LAT for VL was first introduced by Cummins et al. in 1994. The principle of the 
test is the agglutination reaction between anti-leishmanial antibodies in the serum and 
latex particles which are coated by leishmanial antigen.  
 
To sensitize latex particles, Cummins et al. used soluble Leishmani antigen which was 
prepared from pelleted promastigotes of L. donovani (MHOM/SD/68/1S) harvested from 
a 72 h culture in tryptose broth. The pellet was washed 3 times with phosphate-buffered 
saline before freezing at -20oC for 48 h, followed by centrifugation at 13 000 rev/min for 
2 min in a microcentrifuge (MSE/Fison). Then the supernatant liquid was removed and 
its protein content measured by Folin method (Lowry et al., 1951) and standardized by 
dilution to 3-5 mg/mL. 
 
Latex particles were sensitized by adding equal volumes of the soluble antigen to a 
10% v/v suspension of latex particles (0.8 µm; Polymer Laboratories) and rotating for 1 h 
on a Spiromix® rotator. The suspension was left at 4oC overnight, before centrifuging at 
13,000 g/min, discarding the supernatant liquid and resuspending the pellet to 5% 
concentration in phosphate buffer, pH 8.0. The LAT was then performed by mixing equal 
volumes of test serum and sensitized latex on a microscope slide and rotating it for up to 
2 min. The test reported a sensitivity of 93% and a specificity of 100% when it was 
introduced (Cummins et al, 1994).  
 
Many latex agglutination tests had been developed successfully to diagnose several 
diseases and infections including meningococcal infection (Alliluev et al., 1999), Group 
B streptococcal infection (Webb and Barker, 1980), cryptococcal meningitis (Khyriem et 
al., 2003), invasive aspergillosis (Hopwood et al., 1995), brucellosis (Abdoel et al., 
2007). However, few were developed for parasitic diseases (Robert et al., 1990). This 
may be due to the difficulties with great number of cross reactions take place in parasitic 
infection comparing to bacterial infection. Nevertheless, a latex agglutination test had 
been developed for detection of Trypanosoma brucei gambiense antibodies in the 
cerebrospinal fluid of infected patients (Buscher et al., 1999). This test achieved 
specificity of 99% and it sensitivity ranged between 83.8 and 100% depending on the 
geographical origin of the sample. 
 
1.1.5.5.8. Lateral Flow test (LaFT) 
Currently, there is no lateral flow assay developed for VL diagnosis, although many 
diagnostic tests are based on this technique. As in rK39 dipstick, the test principle is 
immunocromatogrophic reaction between antigen and antibodies. However, in contrast to 
rk39 dipstick, no washing step is required in LaFT and this make it easier, faster and 
more convenient (Schallig et al., 2001). The test compose of a plastic cassette that 
contains a strip of nitrocellulose paper on which a smooth line of a particular antigen or 
antibody is sprayed. Conjugated colored particles, like latex or gold nanoparticles, used 
to detect the underlying immunological reaction. 
 
Many forms of LaFT have been developed for diagnosis of Helicobacter pylori with 
sensitivity and specificity of 77.8% and 79.3% respectively (Kaklikkaya et al., 2006). 
Another LaFT developed for leptospirosis scored sensitivity 84.6% of and specificity of 
86% (Sehgal et al., 2003). Buher-Sekula et al. 2003 developed LaFT for leprosy with 
sensitivity and specificity 97.4% and 90.2% respectively. In Turkey, a newly developed 
LaFT for diagnosis of brucellosis was found to have sensitivity of 100% comparing to 
culture (Irmak et al., 2004). Recently, a new LaFT developed to diagnose Trypanosoma 
cruzi had a sensitivity of 99.2% and a specificity of 99.1% (Houghton et al., 2009). 
 
 
 
Part Two: Visceral leishmaniasis in Sudan 
 
 
1.2.1. History and epidemiology 
 
In 1904, the first case VL in Sudan was diagnosed in Meshra-er-Req town in Bahr-el-
Ghazal district, southern Sudan. The patient was an 8 years old boy (Neave, 1904). In 
subsequent years several other cases were reported mainly in the eastern region between 
Sennar and Kassala up to Ethiopian border, which was considered as the possible 
introduction origin (Bousfield, 1910). The disease, however, was familiar to the local 
people who thought it had been introduced from west Africa by the Baggara in the time 
of the Mahdi, around 1880, and was known by many names as simeih (beautiful), marad-
el-seyid (disease of the south) and abu safar (traveler) (Zijlstra and El Hassan, 2001). It 
occurred mainly along water courses and streams and in the period after the rains (Kirk, 
1939). Other new, small foci were identified in subsequent years, such as Kapoeta in 
Equatoria Province in the south and Darfur Province in the west (Zijlstra and El Hassan, 
2001). Sporadic cases were reported from Kordofan, originating from Talodi, Um- Ruaba 
and Urn-Talha (Archibald, 1914). One case occurred in 1922 in a village situated on the 
Blue Nile River near Khartoum (Archibald, 1923). In the Fung area (Central State) 300 
cases were reported between 1933 and 1936 (Henderson, 1937).  
 
In the 1950s, Blue Nile Province remained the main endemic area although the 
distribution remained patchy, with Singa in Blue Nile Province, Kanoeta in Eauatoria and 
Gedaref in Kassala Province as the main foci (Bayoumi, 1979). Over 80% of the reported 
cases were seen in the hospitals of Singa, Sennar and Gedaref. From 1958 to 1961, over 
5000 cases were reported, but after that the incidence fell sharply (Yousif, 1967). The 
area north of Khartoum was considered to be free of VL, but in 1962 one case from 
Ailafoon, near Khartoum, and a second case from Abydia in Nile Province, on the 
southern tip of the Nubian desert, were reported (Sati, 1982). A cluster of 22 cases was 
found in Khogalab, 20 km north of Khartoum in1976 (Hamza et al., 1976). Another 
sixteen confirmed cases, originated from an area along the White Nile river, were seen in 
1982 (Ahmed et al., 1988). Between 1985 and 1987, a total number of 1,300 patients 
recorded annually in Sudan, more than 75% were treated in the hospitals of Gedaref and 
Hawata, a small rural town 100 km south of Gedaref (Zeese and Frank, 1987). From 1990 
onwards, VL was seen in members of Misirya tribe from southern Kordofan, among 
whom the disease had been previously unknown. More than 350 patients were admitted 
in many hospitals in Khartoum between1990 and 1992 (El Hassan et al., 1993a). In a 
study conducted in Urn-Salala village situated on Rhad River, In Gedaref State, the 
annual incidence of VL was 38/ 1000 person-years (Zijlstra et al., 1994). 
 
1.2.2. Outbreaks 
 
Up to 1940, the disease remained more or less stable in the endemic area without major 
outbreaks. Small outbreaks occurred in military patrols in 1913 Kurmuk along the 
Ethiopian border, in 1921 in Jongol’s Post in Melut district (Archibald, 1923), in 1938 in 
Wad Arud, on the upper reaches of the Atbara river (Kirk, 1939) and in Lokitaung, a post 
in Kenya near Lake Turkana in 1942 (Cole et al., 1942). The first major outbreak in the 
civil population occurred in the area east of the town of Melut, in Upper Nile Province 
among the Dinka (Tephenson, 1940). It was estimated that at least 300 cases had 
occurred, with a death rate of 80% (Zijlstra and El Hassan, 2001). A particularly severe 
outbreak occurred in 1956 in the southern Fung area of Blue Nile Province. The affected 
area included known foci like Wad Arud and Melut, and also Jongol’s Post and Kurmuk 
(Sati, 1958). A number of tribes were affected by this epidemic including the Jum-Jum, 
Surkum, Maaban, Uduk and Dinka. Another outbreak with over 200 cases was in the 
Khor Falus area in the beginning of sixties decade. This was the first reported outbreak 
south of the Sobat River in Upper Nile Province (Van Peenen and Reid, 1963). A major 
outbreak thought to have affected about 100,000 people in the area around Melut started 
in 1979. Almost a thousand patients were treated between February 1980 and April 1981 
In Melut hospital (Sixl et al., 1989). 
 
 In 1988 a major epidemic of VL was taking place in West Upper Nile Provenance, 
especially around Duar, in the southern Sudan. Surveys in the area showed that the 
epidemic had already started in 1984 but, because of the isolation of the area caused by 
the war, this was not noticed until 4 years later (Zijlstra and El Hassan, 2001). The first 
evidence of the epidemic was seen in Khartoum, where hundreds of people belonging to 
the Nuer tribe, originating from West Upper Nile, presented with VL (De Beer et al., 
1991). Over 800 patients were treated and the case fatality rate was 11.3% (Zijlstra et al., 
1991a). In West Upper Nile itself around 20,000 to 30,000 people estimated to have died 
by late 1988 (Perea et al., 1991). Two emergency treatment centers were established 
there in which thousands of patients were treated, most of them desperately ill. Between 
1989 and 1995, more than 19,000 patients were diagnosed and treated in both locations 
under primitive conditions (Veeken, 1999). It is estimated that, between 1984 and 1994, 
around 100,000 deaths occurred because of VL among 280,000 people in the epidemic 
area with overall death rate of 38-57%, reaching 70% in the most highly affected areas 
(Seaman et al., 1996). Another more recent VL outbreak started in 1995 in the Atbara 
River area in eastern Sudan. A significant increase in VL incidence was recorded in a 
dozen villages in this area. One village, Barbar El Fugara, accounted for half of the total 
number of cases recorded at the regional hospital with 16.5% VL prevalence (El Safi et 
al., 2002). 
 
 
1.2.3. Parasite 
 
In one study, several Sudanese isolates obtained in Malakal by growth on medium 
containing immune serum were serologically compared. two strains from human VL 
cases, 3 from patients with cutaneous leishmaniasis, 2 from naturally infected sand flies 
(P. orientalis), one from Rattus rattus (Black rat), one from Arvicanthis niloticus 
luctuosus (African grass rat), one from Acomys albigena (white spiny mouse), one from 
Genetta genetta senegalensis (Senegalese common genet), and one from Felis serval 
phillipsi (African wild cat) were studied. All the strains were indistinguishable from each 
other, suggesting that VL in the Sudan is a zoonosis and that L. donovani is transmitted 
by P. orientalis (Adler et al., 1966). These findings were later confirmed by excreted 
factor (EF) serotyping (Schnur and Zuckerman, 1977) and by deoxyribonucleic acid 
(DNA) buoyant density and enzyme variant determination (schnur et al., 1981). Later, 
different studies on isoenzyme analysis of strains from isolates collected in patients, 
animals and sandflies from different parts of the country revealed that all zymodemes are 
closely related (Zijlstra and El Hassan, 2001). They all are on the cladogram belong to 
the L. donovani sensu latu cluster (Rioux et al., 1990) and this indicates the homogeneity 
of L. donovani strains found in Sudan (Ibrahim et al., 1995). This is in contrast to the 
isoenzyme heterogeneity found in isolates of L. major causing cutaneous leishrnaniasis 
(Zijlistra and El Hassan, 2001). 
 
1.2.4. Vector 
 
The first record of a sandfly found in an area endemic for VL was in a collection made 
by R. G. Archibald in El Fasher, Darfur. The fly was identified as Phlebotomus 
langeroni, but it was probably var. orientalis (Theodor, 1938). Important work by Kirk 
and Lewis (1955) showed that P. orientalis fulfilled the criteria for a primary vector: its 
distribution matched the distribution of VL cases, the flies could be easily infected with 
Leishmania and the parasite underwent ‘anterior’ development in the fly (Zijlistra and El 
Hassan, 2001). Major progress was made after noticing that P. orientalis adults first 
appeared in the middle of the dry season, their numbers increasing considerably until the 
rainy season when they fell sharply; their main period of activity was from April to June 
(Hoogstraal and Heyneman, 1969). It was found only in Acacia seyal-Balanites 
aegvptiaca forests and in villages in or near these forests. Leishmania infection was 
found in P. orientalis collected from the forests, and was proved by the inoculation of 
hamsters (Hoogstraal and Heyneman, 1969). Other sand flies collected in the forest, such 
as P. heischi, appeared much less stable in number than P. orientalis and contained 
metacyclic parasites that did not infect hamsters and have remained unidentified (Zijlistra 
and El Hassan, 2001). 
 
P. orientalis is determined to be the vector in the epidemic took place in southern 
Sudan in the early nineties. Transmission appeared to take place outside the villages in 
Acacia-Balanites woodland or in villages within the forest. Ten percent of P. orientalis 
were found to be infected with Leishmania (Schorscher and Goris, 1992). Infection rates 
are high, making it an extremely efficient vector. These infection rates show seasonal 
manner. They are high during March-April compared to those found at the beginning of 
the rainy season. However, the risk of human infection does not reduce because at the 
same time the abundance of the vector increased 20-fold and each human may therefore 
be bitten more frequently (Elnaiem et al.,1998). 
 
1.2.5. Reservoir 
 
Efforts were begun to identify animal reservoirs of the infection shortly after the first 
cases of VL had been diagnosed in Sudan. Animals inhabited endemic areas were 
investigated for possible natural infections. Amastigotes were found sporadically in dogs 
(Bousfield, 191l), monkeys (Marshall, 1911), a fox (Kirk, 1956) and in a cutaneous sore 
on the belly of a pony (Bennett, 1935). Negative results were obtained in another large 
number of animals: cats, fowls, sheep, goats, mice, squirrels, bats, lizards, geckos, 
pigeons, guinea fowl, crocodiles, hyenas and various species of gazelle (Archibald, 
1923). In west Upper Nile Provenance, natural infections were found in 2 rodent species 
(Aruicanthis niloticus luctuosus, the Nile grass rat, and Acomys albigena, the spiny 
mouse) and 2 species of carnivores (Genetta g. senegalensis, the Senegal genet, and Felis 
serval phillipsi, the Sudanese serval). No infection was found in the domestic dogs that 
were abundant in the area (Hoogstraal and Heyneman, 1969). Leishmania species also 
were found in 58% of 138 geckos (Hemidactylus turcicus) (Mcmillan, 1965).  
 
Searching for potential parasite reservoir was not always successful. In Melut district, 
among 628 small mammals investigated, Leishmania was found in only one animal (Sixl 
et al. 1987). Another study examined 1600 small mammals of several species (Mustomys 
sp., Arvicanthis niloticus, Acomys sp., Taterillus sp., Ictonyx  triatus, Procavia ruficeps) 
in Gedaref Province without detecting Leishmania infection (Zeese and Frank, 1987). 
 
It has been suggested that PKDL cases may act as a human reservoir of Leishmania 
parasites, but to what extent is unknown (Kordofani et al., 2001). Transmission of 
parasite from PKDL cases to other individuals by sandflies was proved to be responsible 
to massive epidemic of kala-azar in India (Das et al., 2009). In Sudan, this link between 
PKDL and epidemics is yet to be confirmed. However, PKDL important role in 
interepidemic periods of VL is well known. (Zijlstra et al., 2003). El Hassan and Khalil 
(2001) noticed that, paradoxically, the more VL patients are treated, the higher the 
frequency of PKDL. They suggested the more vigorous treatment regimen of PKDL in 
order to reduce infection rate.  
 
1.2.6. Transmission 
 
Early observations on the occurrence of VL cases in the Dinder Park and several other 
uninhabited areas suggested zoonotic transmission of the disease (Hoogstraal and 
Heyneman, 1969). Anthroponotic transmission was proposed early by Kirk (1956) but its 
important role became highlighted in nineties after Zijlstra et al. (1994) found over 50% 
of VL patient developed PKDL in Gedaref States. The parasite was found to be abundant 
in the skin lesions of these patients. They are thought to cause infection of the sandflies 
and, therefore, transmission the disease to other human victims (Zijlistra and El Hassan, 
2001). Materno-fetal transmission of the disease resulting in congenital kala azar was 
rarely reported in some endemic areas like India (Yadav et al., 1989) and Kenya 
(Nyakundi et al., 1988). The first case reported in Sudan was described by Eltoum et al. 
(1992). They also described leishmaniasis of the placenta in a 5-months fetus. There is no 
report from Sudan of other rare routes of transmission such as sexual transmission, 
transdermal infection by a bite from an infected animal or by handling infected materials 
(Zijlistra and El Hassan, 2001). 
 
1.2.7. Clinical feature 
 
Siddig et al. (1990) described the clinical features of 99 parasite proven Sudanese 
patients with VL. Most patients were young (teens to 20's). Fever, weight loss despite an 
excellent appetite, insomnia, epistaxis and abdominal pain were the most common 
symptoms. Hepatosplenomegaly was universally present while generalized 
lymphadenopathy was found in 72%.  This last sign is a unique feature of Sudanese VL 
as it is rarely seen in other endemic areas. The high prevalence of lymphadenopathy has a 
wide range of implications: for diagnosis, i.e., the use of lymph node aspiration; for 
response to treatment, i.e., the resolution of lymphadenopathy; and for studies of 
immunoregulation in this systemic infection. In another study conducted between 1996 
and 1997 during VL epidemic in Barbar El Fugara village, 85.8% of parasitologically 
proven VL patients were found to have lymphadenopathy (El Safi et al., 2002). Same 
study found that 79% of total numbers of VL patient were lying in 4-20 years age group 
with slightly higher incidence in male than female (1.3:1).  Skin hyperpigmentation, from 
which kala-azar originally obtained its name, is not frequent in Sudanese patient. The 
most common cutaneous manifestation, though it may develop after cure, is PKDL.  
More than 50% of Sudanese VL patients develop PKDL after incomplete or partial 
treatment with sodium stibogluconate (e.g. Pentostam®) (Zijlistra et al., 1994). The time 
interval between VL curing and PKDL development varies between endemic areas. It is 
usually less than six months in Sudan but can extend to several years in India (Kordofani 
et al., 2001). Another uncommon skin manifestation is tinea versicolor which is seen in 
10.8% of Sudanese VL patients (Hashim and El Hassan, 1994). The most important 
disease that gives a similar presentation as VL, in Sudan, is malaria. Therefore malaria 
should be properly ruled out, and treated, before considering VL (El Safi et al., 1991).  
 
1.2.8. Laboratory diagnosis 
 
1.2.8.2 Parasitology 
 
1.2.8.2.1. Direct microscopy 
Direct microscopy of stained aspirates from spleen, bone marrow and lymph nodes is 
the widely used, as first diagnostic line, both in field and central hospitals. Because of 
being easier and more convenient, Lymph node aspiration, usually inguinal, is the 
commonest over the 3 methods. However, its sensitivity (52-58%) is lower than that of 
bone marrow aspiration (52-85%) and splenic aspiration (93-99%) (Zijlstra et al., 1992; 
Siddig et al., 1988). One recent study reported higher sensitivity (65.1%) of lymph node 
aspiration with similar accuracy as splenic aspiration for cure testing (Babiker et al., 
2007). Although splenic aspiration represents the most sensitive method, it carries the 
risk of sever hemorrhage and, ideally, should not be performed without checking 
coagulation profile.  However, some literatures from Kenya are in favor of carrying out 
such a procedure under field condition by experienced hands since this complication is 
rarely reported (Kager and Rees, 1983). Direct microscopy for other tissue materials like 
liver and blood, in immunocompermised, was also described for VL diagnosis but less 
frequently used in Sudan (Zijlstra and El Hassan, 2001).  
 
 1.2.8.2.2. In vitro Culture and animal inoculation 
Using of culture media for inoculation of fluid from tissue aspirates may increases the 
sensitivity, especially for direct microscopy-negative results (Boelaert et al, 2004). 
However, parasite culture is costly and time-consuming, and requires expertise and 
expensive equipment. Therefore it is not used routinely for VL diagnosis in Sudan. Its use 
is restricted to referral hospitals or research centers. The same is also applied for animal 
inoculation. 
 
 
1.2.8.2 DNA detection methods 
 
Application of PCR in the field of VL in Sudan commenced in early 1990s. It was used 
to identify Leishmania parasite in tissue specimen from lymph nodes and bone marrow 
(El Hassan et al., 1993b). Diagnosis of VL by PCR using peripheral blood samples was 
evaluated in Sudan. In one study, it revealed sensitivity of 70% only in parasitologically 
proven cases (Osman et al., 1997b). Another study used blood collected in filter paper 
reported sensitivity of 92.5% (Andersen et al., 1997). In addition PCR-based testing of 
lymph-node aspirates after treatment may be used as test of cure and in the follow-up of 
patients. PCR also proved to act as a good prognostic marker for the future development 
of PKDL (Osman et al., 1997a). However, the fact of being an expensive and 
complicated technique restricts PCR usage, in Sudan, to research centers and some 
central hospitals only.  
 
  
1.2.8.3 Serology 
 
1.2.8.3.1. Indirect immunofluorescence test (IFAT) 
Unlike other endemic areas as Brazil, the immunofluorescence antibody test (IFAT) has 
not been used widely in Sudan. Only few research studies on this serological method are 
available. Abdalla (1980) found 66% of 50 sera from confirmed VL patients positive in 
the IFAT at a dilution of 1:400, but 16% of 150 controls from the endemic area tested 
positive at the same dilution. El Amin et al. (1986) found ELISA more specific and 
sensitive that IFAT. In one comparative study conducted in Gedaref State, IFAT showed 
lower sensitivity (90.4%) than DAT (96.1%) but again higher than ELISA (85.5%) (El 
Safi et al., 2003) 
 
1.2.8.3.2. Enzyme-linked Immunosorbent Assay (ELISA) 
The standard ELISA for VL diagnosis using soluble L. donovani antigen was tested in 
Sudan (El Safi and Evans, 1989). It revealed 60% sensitivity in parasitologically VL 
confirmed cases. rK39 antigen-based ELISA was evaluated in Sudan and reported 
sensitivity of 93% and specificity of 80% (Zijlstra et al., 1998). It was suggested that the 
presence or absence of antibodies to rK39 may predict progression to VL or self-healing, 
respectively. Beside that, it could detect infection 6 months earlier in about 40% of 
patients with PKDL and individuals with subclinical infection.  However, rK39 ELISA 
does not allow discrimination between active infection and past infection. Recently, 
Abbas et al. (2006) developed VL diagnostic ELISA based on antigen prepared from 
whole promastigote treated with β-mercaptoethanol. They reported sensitivity and 
specificity of 98.8% and 100% respectively. ELISA usage in Sudan is limited by the 
technique complexity. 
 
1.2.8.3.3. Direct Agglutination Test (DAT) 
The DAT is the most common used serological tool is Sudan. Different values of test 
accuracy have been reported in several studies over the past two decades. El Safi and 
Evans (1989) found sensitivity of 67% of the DAT in parasitologically confirmed cases. 
In another study published in the same year 100% concordance was found between the 
DAT results and the parasitological diagnosis in 40 confirmed cases. It also showed low 
insignificant titers on sera collected from patients infected with other endemic diseases as 
brucellosis, enteric fever and malaria. Therefore, it was concluded that DAT has high 
potentials for routine diagnosis in Sudan (Abdel-Hameed et al., 1989). 
 
Zijlstra et al. (1991) compared DAT to lymph node and splenic aspiration in 132 
suspected VL patients and reported sensitivity and specificity of 94% and 72% 
respectively. They recommend DAT to be used as screening test as it has high negative 
predictive value (92%). After the freeze-dried (FD) form of DAT antigen being 
introduced (Meredith et al., 1995), it was compared to the aqueous antigen in Sudan 
(Zijlstra et al., 1997). It showed similar performance besides having the advantage of 
being stable at ambient temperature. In Gedaref State, a sensitivity of 95.9% and a 
specificity of 99.4% were found at a 1: 8,000 cut-off titer when 49 parasitologically 
confirmed cases were compared with 157 healthy controls (Boelaert et al., 1999b). 
Veeken et al. (2003) evaluated DAT in 50 VL patients and 27 endemic negative controls 
from northeastern Sudan. They reported sensitivity and specificity of 84% and 85% 
respectively. Another study in the same endemic area in Gedaref State reported higher 
figures of both sensitivity and specificity (96.8% and 96.2% respectively) (Abdallah et 
al., 2004).  
 
In one recent multi-center study, FD-DAT was found to have sensitivity and specificity 
of 85.7% and 98.2% respectively in Sudan (Boelaert et al., 2008). These two figures 
represented the lowest sensitivity and the highest specificity over the all five centers 
participating in the mentioned study. This obviously highlights the challenge of choosing 
a cut-off titer to distinguish between positive and negative samples and thus give the most 
accurate DAT results. Another drawback of the DAT is being, like most of the 
serological test, unable to differentiate between current and previous infection. 
 
 
 
1.2.8.3.4. rK39 dipstick test 
This new rapid test has been evaluated extensively in Sudan over the last decade. 
Zijlstra et al. (2001) compared between the performance of DAT and rK39 dipstick on 55 
serum samples from parasitologically proven VL patients. rK39 came positive in only 37 
samples (67%) while DAT in 50 ones (91%). Another study carried out in one of MSF 
VL treatment center, reported high sensitivity (92%) but with low specificity (59%) for 
the rK39 dipstick test (Veeken et al., 2003). Ritmeijer et al. (2006) found difference in 
performance of the test among VL confirmed and VL suspect cases. While the test 
showed good sensitivity over the first group (90%), it only reported 81% for the letter. 
Test sensitivity again was found low (77.9%) in the recent multicenter study, although it 
showed good specificity (91.8%) (Boelaert et al., 2008). In the same study, rK39 dipstick 
test showed weak sensitivity figures in other East African endemic areas (75.4%, 84.7% 
in Ethiopia and Kenya respectively) compared to its high performance in Indian sub-
content (99.6% and 96.5% in India and Nepal respectively) (Boelaert et al., 2008). In one 
recent study in Turkey, the sensitivity of rK39 was just 41.3% compared with PCR 
(Ozerdem et al. 2009). The exact cause of this behavior is not yet well known. Some 
researchers attributed the different test values in Sudan to the different test kit brand and 
the manufactured company. 
 
1.2.8.3.5. Latex agglutination test for urinary antigen (KAtex) 
Shortly after KAtex was introduced by Attar et al. (2001), it had been evaluated in 
Sudan (El Safi et al., 2003). It showed sensitivity of 95.2% and specificity of 100% in 
addition to the advantage of being able to diagnose Leishmania-HIV co-infection. In 
2007, Katex was evaluated again in Sudan, as part of a larger multi-center evaluation, and 
revealed sensitivity and specificity of 79.2% and 98.3% respectively (Boelaert et al., 
2008). KAtex has got the advantage of being non invasive, however, the need of boiling 
of urine may make the test not convenient. 
 
1.2.8.3.6. Latex Agglutination Test (LAT) 
This agglutination assay, which was described by Cummins et al. (1994), uses serum to 
react with L. donovani coated latex particles. Only one study evaluated this test in Sudan. 
Sera of 60 confirmed VL patients and 75 healthy controls were tested and sensitivity of 
88% and specificity of 96% were recorded (Moody and El Safi, 1996). The authors 
attributed the low sensitivity, compared to the one obtained by Cummins et al. (93%), to 
the fact that some of the sera were stored for a considerable time. They recommended the 
use of fresh serum samples for further evaluation. 
 
 
 
 
 
2. Justification 
 
VL is fatal if it is not adequately treated. The drugs currently used to treat VL can have 
severe side effects and the clinical presentation of VL is not sufficiently specific to guide 
treatment. Highly accurate (both sensitive and specific), cheap and simple rapid 
diagnostic tests (RDTs) are therefore crucial for case-management of VL. Early case 
detection followed by adequate treatment is also central to control of VL because, as yet, 
no vaccine is available and the long-term impact of vector control is unclear. Although 
the need for accurate VL diagnostics is obvious, innovation in this field has been slow. 
Since the 1980s, the main objective of VL diagnostics development has been to replace 
the direct demonstration of parasites in tissue smears, a technique that is invasive and 
requires considerable expertise, by a ‘field test’ that is more appropriate for use in a VL 
endemic fields.  
 
Several serological tests have been developed, but many of them are not suitable for 
field diagnosis. VL represents a major health problem in many rural parts of Sudan. Most 
of current diagnostic methods for VL in the country have some concern about their 
applications. Some of them are time consuming (e.g. DAT) (El Safi et al., 2003). Some 
others are complex and need high technical expertise (e.g. PCR) (Osman et al., 1997b). 
In some tests, there is a lot of concern about sensitivity (e.g. rK39) (Boelaert et al., 2008). 
Therefore, there is a genuine need for a diagnostic test for VL that is suitable for the use 
in peripheral health service facilities. 
 
This study was a part of a large project funded by TDR/WHO aims to develop simple 
and rapid diagnostic tests for VL with subsequent laboratory evaluation then producing 
the final test format before performing Part 11 and  large-scale field evaluation. This 
study persuaded Latex Agglutination Test (LAT) and Lateral Flow Assay (LaFT) to be 
developed. This choice was made because:   
 
- The technological expertise to perform these tests is minimal. 
- They do not require specialized laboratory equipments. 
- The results of testing will be available almost immediately. 
- They may ultimately prove more cost-effective than currently used diagnostic 
tests, in particular, when used in mass-screening surveys. 
 
In addition to the above mentioned reasons, LAT for VL has been developed previously 
(Cummins et al., 1994) and showed performance higher than lymph node and comparable 
to bone marrow aspiration in small panel of sera from Sudan (Moody and El Safi, 1996). 
This indicates its capability for more development to fulfill the requirements of the 
acceptable diagnostic test as many latex agglutination-based tests for detection of 
aspergillosis (Hopwood et al., 1995), group B streptococci infection (Webb and Baker, 
1980), syphilis (Fears et al., 2001), typhoid fever (Kaur et al.,1990), adenovirus diarrhea 
(Grandien et al., 1987) and many other diseases. The same is also applied on LaFT which 
has been developed successfully to diagnose variety of infections. Moreover, Biomedical 
Research department of Royal Tropical Institute, which is the main partner in this project, 
produces and distributes 4 kinds of lateral flow assays for the diagnosis of brucellosis 
(Irmak et al., 2004), leptospirosis (Smits et al., 2001 ; Eapen et al., 2002), leprosy 
(Bührer-Sékula et al., 2003) and typhoid (Pastoor et al., 2008). Therefore, it has all the 
necessary expertise for development of a similar test for VL is available which makes this 
choice preferable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Objectives 
 
3.1. General objective: 
 
The overall objective of this study is to develop a diagnostic test of VL that is simple, 
affordable and has a high sensitivity and specificity and accordingly is suitable for use at 
primary   health level.  
 
 
3.2. Specific objectives: 
 
The study has the following specific objectives: 
 
1. Development of proof of principle (Phase 1 evaluation) of the LAT for the 
diagnosis of VL using 3 forms based on plain latex, carboxylated latex and 
magnetic beads. 
 
2. Development and Proof of principle (Phase 1 evaluation) of the LaFT for the 
diagnosis of VL. 
 
3. Comparison of results with the DAT. 
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4. Materials and Methods 
 
4.1. Serum Samples 
 
Serum samples, on which the study was conducted, were classified into three groups: 
sera from VL patients, sera from patients with other diseases than VL and sera from 
healthy individuals. VL patients’ sera included 51 serum samples from Sudan, 4 from 
Kenya and 100 from Brazil. All sera were from VL patients were proven positive by 
parasitology i.e. amastigotes were detected in lymph node, bone marrow or splenic 
aspirates from the patients. The healthy controls group included 100 samples from 
healthy Dutch individuals, provided by the Central Blood Bank (CLB) in addition to 29 
serum samples from healthy Sudanese individuals. 
 
One hundred and fifty serum samples were from patients affected with other diseases 
than VL. From this group, 100 were from Brazilian patients and 50 sera from Dutch 
patients. The list of “Other diseases than VL” included malaria (9 samples), leptospirosis 
(12), Crohn’s disease (8), sarcoidosis (8) and other unidentified diseases (113). All serum 
samples in this group were obtained from Dutch patients. The DAT was used to test all 
sera of all groups (Meredith et al., 1995). A DAT titer of 1:800 or higher was considered 
positive. 
 
 
4.2. In vitro culture 
 
Leishmania donovani MHOM/SD/68/1S was used in this study. The parasites were 
usually left to grow for 3-5 days in RPMI medium (GIBCO®) that is supplied with 15% 
foetal bovine serum (GIBCO®) and Penicillin/Streptomycin mixture (GIBCO®). Parasites 
were microscopically examined for growth rate by counting, morphology and mobility.  
Cultures were harvested in late log phase by centrifugation at 3,500 g for 10 minutes at 4 
°C and washed once with PBS. 
 
 
4.3. Antigens 
 
4.3.1. Sonicated Antigens 
The harvested Leismania promastigotes, about 2.3 x 107 promastigote per mL, were 
disrupted by sonification using a BRANSON® sonifier. The produced raw sonicate 
mixture is separated by centrifugation for 30 min at 20,000 g at 4 °C into (i) soluble 
supernatant and (ii) insoluble sediment fragments.  
 
4.3.2. Acetone extracts 
Four types of acetone extracted antigens were prepared in the same way using different 
antigens. To one volume of a particular antigen fraction (as mentioned in 4.3.1.) three 
volumes of acetone (MERCK®) was added, followed by incubation at 4 °C for 24 hours. 
The mixture was centrifuged at 10,000 g for 10 minutes. The supernatant was discarded 
and the sediment was left to dry before resuspending in PBS. The 4 types of acetone 
extracted antigens are: 
(i) Acetone extract of the raw sonicate.  
(ii) Acetone extract of the sonicate supernatant. 
(iii) Acetone extract of the sonicate sediment. 
(iv) Acetone extract of intact promastigotes. 
 
4.3.3. Intact Promastigote-based Antigens 
The promastigote cell wall components are responsible for triggering the majority of 
antibodies response against the parasite (Bray et al., 1976). This hypothesis is the base of 
many tests such as DAT. In this study we have tested different antigens fractions derived 
from intact promastigotes. Most of these antigens were used for the lateral flow test. This 
category comprises: 
(i) Whole intact promastigotes. 
(ii) Trypsin treated promastigotes: 2-3 ml of live promastigotes (containing about 2 x 107  
parasites per ml) were suspended in 100 mL PBS, pH 7.7,  containing 10 mg of trypsin 
(SIGMA®) and incubated for 45 minutes at 37 °C. Then the mixture was centrifuged for 
10 minutes at 3,ooo x g and the sediment was washed once with PBS and resuspended in 
total volume of 3 ml of PBS. 
(iii) Trypsin and formalin treated promastigotes: As above but after trypsin treatment 
Formaldehyde (MERCK®) was added to a final concentration of 1%.  
(iv) Promastigotes based on DAT antigen. Freeze dried DAT antigen was solubilised in 
Milli Q water to a final concentration of 5 x 107 Parasites per mL. 
 
4.3.4. Recombinant Antigens 
Only one recombinant antigen was included in this study. It is Leishmania infantum 
Silent Information Regulatory 2 protein (SIR-2) which was kindly provided by Dr. 
Anabela Cordeiro-da-Silva from Porto University in Portugal (Silvestre et al., 2006). 
 
 
4.4. Analysis of the antigens: 
 
4.4.1. Protein Concentration 
Protein content of the different antigen fractions was measured with a commercial kit 
(PIERCE®) which is based on Bicinchoninic Acid (BCA™).  
 
4.4.2. SDS Polyacrylamide gel electrophoresis 
The antigenic fractions were analyzed in SDS PAGE using different concentrations of 
polyacrylamide ranging from 8 to 12%. The BIO-RAD® mini apparatus was used for this 
procedure. The gels were stained by Commassi Blue. 
 
4.4.3. ELISA 
Antigens were tested in the ELISA with a panel of positive and negative control sera. 
The conditions of the ELISA were optimized for optimal performance with respect to 
sensitivity and specificity. Optimization comprised of; 
1. Antigen dilution used for coating plates: 1:100, 1:200, 1:400, 1:800, 1:1000, 
1:2000, 1:4000, 1:6000, 1:8000 and 1:10000 
2. Serum dilution: 1:200, 1:400, 1:800, 1:1600 and 1:3,200. 
3. Conjugate dilution: 1:5000, 1:10000, 1:20000 and 1:40000. 
4. Substrate: Tetramethlybenzidine (TMB) and O-Phenylene Diamine (OPD). 
5. Absorbance wave length: 450 nm. 492 nm and 630 nm. 
 
4.4.4. Analysis of antigens by Western Blot 
Antigens were run on western blot and incubated with VL and negative control sera in 
order to examine antigens that are specific for VL and to select these antigens as possible 
candidates for rapid diagnostic tests. Wet blotting was performed using BIO-RAD® 
blotting system. 
 
4.5. Agglutination Assay 
 
4.5.1. Plain latex 
 
The latex agglutination assay is performed by mixing on an agglutination card 5 µl 
serum with 5 µl antigen-coated, dyed latex beads. The result is obtained within 2 min 
(Smits et al., 2000). 
 
4.5.1.1. Latex particles size, color and brands 
Different sizes were tried through out the study period: 
a. 0.15 µm, Red, ESTAPOR® 
b. 0.20 µm, Red, PPLYMER LABORATORY® 
c. 0.30 µm, Black, ESTAPOR® 
d. 0.50 µm, Blue, ESTAPOR® 
e. 0.80 µm, Blue, ESTAPOR® 
 
4.5.1.2. Antigen Dilution 
In this work, equal volumes of antigen and of 3% latex suspension were used for the 
process of sensitization. Antigens were diluted in MQ water and in PBS in the following 
dilution: 1:2, 1:3, 1:4, 1:5, 1:10, 1:20, 1:50, 1:100, 1:1000 and undiluted. 
 
4.5.1.3. Coating Time 
Different coating times were studied to find out their effect on the test performance. 
Thirty minutes, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours and overnight had been all 
tried.  
 
4.5.1.4. Blocking reagent 
To achieve the best test format, many blocking reagents were tried in different 
percentage and in different buffer media. The tested blocking reagents included: 
a. Sikm milk (DIFCO®) 
b. Bovine serum albumin [BSA] (SIGMA®) 
c. Gelatin (FLUKA®) 
d. Casein (SIGMA®) 
e. Glycine (SIGMA®) 
They were tried in different percentage: 5%, 4%, 3%, 2%, 1%, 0.75%, 0.5%, 0.25% and 
0.1%. Like in antigen dilution, blocking reagents were prepared in MQ water and in PBS. 
 
4.5.1.5. Blocking time 
Overnight, 3 hours, 2 hours, 1.5 hours, 1 hour and 30 minutes were all tested. 
 
4.5.1.6. Washing 
Washing steps follow both the coating and the blocking steps. After coating, one hour 
of washing by MQ water takes place. Number, time and type of washing buffer after 
blocking step were all subjected to optimization as the time and speed of the 
centrifugation step after washing. 
 
4.5.1.7. Final Latex Suspension 
Different percentage of latex suspensions in the storage buffer (NaCl/Glycine/Trehalose 
buffer) were tried to be used in the final test format. These include 8%, 6%, 3%, 2% and 
1%. 
 
4.5.1.8. Test Format 
Most of the serological latex tests mix equal volumes of  undiluted untreated serum 
sample and latex reagent for about two minutes to detect agglutination reaction. In 
addition to this conventional format, different modifications were tried on this basic 
assay. These modifications included: 
 
4.1.5.8.1. Changing Serum : Latex ratio: many ratios, instead of 1:1 were tried. 1:2, 
2:1 and 3:1. 
4.1.5.8.2. Serum dilution: dilution of the serum samples prior to mixing with latex 
was tried. Different dilutions were tested like 1:2, 1:5, 1:10, 1:25 and 1:50. 
Serum dilution was tried in normal saline. It was also tried with DAT 
serum diluent (0.1 M β mercaptoethanol) which has a major role in 
eliminating false agglutination in DAT test.  
4.1.5.8.3. Serum inactivation: it was tried to explore any role that it can play in 
eliminating false agglutination in the negative controls. The process is 
carried out by incubating the serum sample at 60 °C for 5 minutes.  
4.1.5.8.4. pH changing: Effect of pH on the agglutination assay was studied by  
mixing different volume of 0.5 M sodium carbonate, pH 9, and 0.1 M 
hydrochloride, pH 3, with the serum and the latex. 
 
 
4.5.2. Carboxylated latex 
 
Carboxylated latex particles (BANG®) with diameter of 0.8 µm were linked to different 
antigens. This was carried out covalent coupling of the antigen to the activated carboxyl 
group on the particles according to the company’s protocol. The test is performed by 
mixing different volumes of latex and serum and rotating. 
  
4.5.3. Magnetic beads 
 
Magnetic beads are basically latex particles with irony core. Carboxylated magnetic 
beads (BANG®), 3.0 µm diameter, have been used in this study. They were covalently 
coupled to different antigens according to the company’s protocol. Antihuman anti IgG 
coupled magnetic beads (BANG®), 1.5 µm diameter, were also used as co-agglutination 
factor. Different test formats were designed by mixing the serum sample with one or both 
mentioned reagents and rotating. 
 
 
4.6. Lateral Flow Assay 
 
The lateral flow test will comprise a composite assay strip contained in a plastic 
housing. The assay is based on the binding of specific antibodies present in the clinical 
sample to the antigen and staining of bound antibodies by colloidal gold-labeled antibody 
conjugate (Eapan et al., 2002; Smits et al., 2003). Tests results are available after 10-15 
minutes. 
 
4.6.1. Nitrocellulose membrane 
Nitrocellulose membranes (NM) with wicking rates of: 65, 90, 135, 180 and 240 were 
used in the development of the assay. 
 
4.6.2. Coating buffer 
Several forms of coating buffer were tested to dilute the antigens before being sprayed 
on NM. These include MQ water, PBS, Potassium phosphate buffer (morality ranged 
from 0.01 M to 0.5 M and pH from 4.9 to 8.2) and Sodium carbonate/ bicarbonate buffer 
(morality ranged from 0.01 M to 0.5 M and pH from 8.5 to 9.2). 
 
4.6.3. Antigen Dilution 
Different antigens were diluted in the coating buffer in the following ratios: 1:2, 1:3, 
1:4, 1:5, 1:6, 1:8, 1:10, 1:12, 1:16, 1:20, 1:24 and 1:30. In addition, antigens also were 
used undiluted and concentrated two times and five times. 
 
4.6.4. Blocking reagent 
To achieve the best test format, many blocking reagents were tried in different 
percentage and in different buffer media. The tested blocking reagents include: 
a. Bovine serum albumin [BSA] (SIGMA®) 
b. Gelatin (FLUKA®)  
c. Sikm milk (DIFCO®) 
d. Polyvinyl alcohol (PVA) (MERCK®) 
e. Polyvinylpyrrolidone (PVP) (SIGMA®) 
They were tried in different percentage in MQ water and in PBS. 
 
4.6.5. Blocking method 
Time of the blocking, the washing buffer, washing time and washing frequency all were 
subjected to modification. 
4.6.6. Drying time and temperature 
After spraying the prepared antigen on NM, they were left to dry either in room 
temperature or in 37 °C. Different drying times were tried: 30 minutes, 45 minutes, 1 
hour, 1.5 hour, 2 hours. 
  
4.6.7. Dilution Buffer 
Several formulas of dilution buffer (running buffer, washing buffer) were tested. It has 
three main constituents: buffer medium, enhancer and blocking reagent: 
4.6.7.1. Buffer medium 
The following buffer media were used: 
a. PBS 
b. Borate buffer 
c. MQ water 
4.6.7.2. Enhancer 
Enhancers are used in the lateral flow assay to enhance and clarify the reaction signal. 
The following substances were used in the dilution buffer as enhancing agents: 
a. Tween20 (MERCK®) 
b. Triton X-100 (SIGMA®) 
c. Sucrose (SIGMA®) 
d. Trehalose (FLUKA®)  
4.6.7.3. Blocking reagent 
Blocking reagents are put in the diluting buffer to help eliminating non-specific 
reaction. BSA (SIGMA®), Skim milk (DIFCO®) and Gelatin (FLUKA®) were used in 
different ratio in this study. 
 
4.6.8. Gold Conjugate 
Immunoglobulin coated 40 nm gold particles (BBI®) were used in this study as signal 
indicator for the lateral flow test. Three factors concerning gold conjugate were subjected 
to optimization: immunoglobulin type, optical density and spray volume.  
4.6.8.1. Immunoglobulin 
Two types ? gout anti-human antibody conjugated gold particles were involved in this 
study; IgG and IgM. Both were coated on 40 nm gold particles commercially available 
from British Biocell international. 
4.6.8.2. Optical Density 
The gold conjugate were prepared and tested in the following optical densities: 5, 10, 
30 and 60 OD. 
4.6.8.3. Spray Volume 
The gold conjugate solution was sprayed on its particular strip in the different volume 
per longitudinal unit. These values were tested: 
a. 2 µl/cm 
b. 3 µl/cm 
c. 4 µl/cm 
d. 5 µl/cm 
e. >5 µl/cm 
 
 
4.6.9. Test format 
Three factors were taken were modified in order to optimize the final test format:   
4.6.9.1. Volume of serum sample 
1 µl, 2 µl, 3 µl, 5 µl, 10 µl, 15 µl and 25 µl of serum samples were tried during test 
development. 
4.6.9.2. Volume of the dilution buffer 
Several volumes of the dilution buffer were evaluated for the optimum test condition. 
These include 75 µl, 90 µl, 100 µl, 125 µl and 150 µl. 
4.6.9.2 Addition of a washing step 
Washing of the strip, with PBS or MQ water, after few minutes of incubation was tried 
to evaluate its possible role in elimination of non specific reactions. 
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5. Results 
 
5.1. Analysis of Antigens 
 
5.1.1. Protein concentration 
 
Protein concentrations of the soluble sonicate, 3 forms of acetone extract antigens 
(soluble sonicate, sediment sonicate and intact promastigote) and SIR-2 recombinant 
antigen were determined. The results are shown in Table 1. 
 
Table 1: Protein concentration of 5 different antigens.  
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: AE: Acetone extract, SIR-2: Silent  regulatory-2 protein. 
 
5.1.2. SDS PAGE 
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis was done for the following 
antigens: 
1. Supernatant of the sonicate: A huge number of proteins were observed containing 
many dominant bands of different sizes between 10 kDa and 170 kDa. 
2. Acetone extracted antigens: There was not much variation between the different 
acetone extracts. They all revealed a large number of proteins distributed between 10 kDa 
and 170 kDa and showed a dominant band of approximately 55 kDa. 
3. Recombinant SIR-2 antigen.  One clear band at 43 kDa was observed as described by 
Cordeiro-da-Silva et al. (2005). 
 
Figure (1) below shows SDS-PAGE analysis of the mentioned antigens in different 
dilutions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antigen Protein concentration (mg/ml) 
Soluble sonicate 
AE of soluble sonicate 
AE of sediment sonicate 
AE of intact promastigote 
SIR-2 
1.7 
1.5 
0.3 
1.3 
0.5 
Figure 1: 
  
SDS-PAGE analysis of SIR-2 
recombinant protein (R) soluble 
sonicate antigen (S) and acetone 
extracted of soluble sonicate 
antigen (5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1.3. ELISA 
 
The supernatant sonicate antigen gave the best results i.e. had the maximum OD 
difference between positive control sera (PC) and negative control sera (NC). For the 
three different acetone extracts examined in the ELISA, the acetone extract derived from 
sediment of the sonicate gave the best results. Recombinant SIR2 showed poor 
performance i.e. no relation between the OD values between VL sera and negative 
control sera.  
 
5.1.4. Western Blot 
 
VL sera gave strong reactions with sonicate supernatant, all varieties of acetone extracts 
and with SIR2 recombinant protein. The sonicate gave many reactive bands of different 
sizes. Three major dominant bands were clearly seen on ``35 kDa, ``55 kDa and `70 kDa. 
No significant differences could be observed between East African and Brazilian group 
of VL sera. Both groups gave very solid reaction with the SIR2 recombinant protein as 
well. Only 2 minor reactions, on ``40 kDa and `4 kDa, were observed between 
supernatant sonicate and healthy Dutch sera (Figure 2). Recombinant SIR2 protein 
produced no reactions at all among this group. Both antigens, supernatant sonicate and 
SIR2 protein, gave strong reactions with at least one sera from “Other Disease” group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
NC PC
Figure 2:  
 
A. SDS-PAGE analysis of 
undiluted soluble sonicate 
antigen (S). 
 
B. Western blot for the same 
antigen after incubation with 
2 serum samples from a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2. Agglutination Assay 
 
5.2.1. Plain latex 
 
5.2.1.1. Optimization 
 
5.2.1.1.1. Latex particles size, color and brands 
Latex particles of 0.8 µm diameter size was the one with best performance i.e. with the 
best positive agglutination signal and with the best clear negative. It also gave the best 
distinction between the weak positive and negative samples (Figure 3). Other sizes vary 
in their performance. Generally the very small sizes, like 0.15 µm, of latex tend to 
produce weaker agglutination with the positive control and, therefore, they frequently 
failed to produce agglutination signal with weak positive controls. On the other hand, 
some other like 0.5 µm latex has greater tendency to make false agglutination. Blue 
colored latex manufactured by ESTAPOR® was used for optimization. However, there is 
no significant difference in performance between it and that of the same size produced by 
SIGMA®. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3:  
 
Weak positive (on the left) and 
negative control sera tested by 0.8 
µm latex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.1.1.2. Antigen 
The following antigens were used to sensitize latex particles: 
(i) Supernatant (soluble) sonicate 
(ii) The sediment of sonicate,  
(iii) Mixed sonicate (without fractionating)  
(vi) AE of soluble sonicate 
(v) AE of sediment sonicate 
(vi) AE of intact promastigote 
(vii) SIR-2 recombinant antigen 
(viii) Modified DAT antigen.  
After elementary optimization, a panel of 20 serum samples (10 positive and 10 
negative) was used for provisional evaluation of the performance of this antigens in order 
to select the most accurate one for further evaluation. The results are shown below in 
Table 2. 
 
Table 2: Results of LAT using 8 different antigens.  
Abbreviations: AE: Acetone extract, SIR-2: Silent regulatory-2 protein, DAT: direct agglutination test. 
The best results in this provisional evaluation were obtained by using AE of soluble 
sonicate antigen (sensitivity of 80% and specificity of 90%). Further evaluation of the 
antigens that showed comparable performance (soluble sonicate, acetone extract of 
soluble sonicate, SIR-2 and DAT antigen-based antigens) took place. A larger panel of 
sera (20 positive and 20 negative) was used this time. Again the AE of soluble sonicate 
gave the best sensitivity and specificity as shown in Table 3. Accordingly, that antigen 
was chosen for further optimization. 
Antigen True Positive 
Agglutination 
True Negative 
Agglutination 
Sensitivity Specificity 
Soluble sonicate 
Sediment sonicate 
Mixed sonicate 
AE of soluble sonicate 
AE of sediment sonicate 
AE of intact promastigote 
SIR-2 
Modified DAT antigen 
8 
2 
5 
8 
7 
7 
7 
8 
8 
10 
9 
9 
8 
8 
7 
8 
80.0% 
20.0% 
50.0% 
80.0% 
70.0% 
70.0% 
70.0% 
80.0% 
80.0% 
100.0% 
90.0% 
90.0% 
80.0% 
80.0% 
70.0% 
80.0% 
 
 
Table 3: Results LAT using 4 selected antigens.  
Abbreviations: AE: Acetone extract, SIR-2: Silent regulatory-2 protein, DAT: direct agglutination test. 
 
 
5.2.1.1.3. Antigen Dilution 
Generally, more concentrated antigen at coating will result in stronger agglutination 
signals. Very strong agglutination is not desired because it will ultimately result in larger 
number of false agglutination with negative control sera. The dilution 1:5 of the acetone 
extract of soluble sonicate antigen gave maximum sensitivity and specificity. Moreover, 
the clearest weak positive and negative results were obtained with this dilution. Table 4 
below shows the results of the performance of different dilutions of the acetone extract of 
soluble sonicate antigen when tested on 8 positive and 8 negative control sera. 
 
More concentrated antigen gave very strong agglutination but with higher numbers of 
false positive results while more diluted antigens tended to miss many weak positive 
controls. Even with dilution of 1:100 positive agglutination signals still could be 
obtained. These dilutions were made in Milli Q water. PBS was also tried to dilute the 
antigens but it was noticed that it had a negative effect on the signal strength. More acidic 
and basic buffers were also tried to study the effect of extreme pH on the process of 
coating and they generally led to disruption and auto-agglutination of the latex particles. 
 
Table 4: Results of LAT using different dilutions of the coating antigen. 
5.2.1.1.4. Coating Time 
No significant differences neither in test accuracy or signal strength could be observed 
between shorter and longer coating time. One hour was determined to be enough time for 
efficient adsorption of the antigen on latex particles surfaces. Latex particles coated with 
the antigen for 30 minutes showed slightly lower sensitivity especially with the weak 
positive samples. Incubation of latex for longer time added no advantage. 
 
Antigen True Positive 
Agglutination 
True Negative 
Agglutination 
Sensitivity Specificity 
Soluble sonicate 
AE of soluble sonicate 
SIR-2 
Modified DAT antigen 
16 
17 
14 
15 
 
17 
18 
14 
16 
 
80.0% 
85.0% 
70.0% 
75.0% 
 
85.0% 
90.0% 
70.0% 
80.0% 
 
Antigen dilution True Positive 
Agglutination 
True Negative 
Agglutination 
Sensitivity Specificity 
Undiluted 
1:2   
1:5 
1:10 
1:20 
13 
10 
8 
7 
5 
3 
6 
8 
9 
11 
100% 
100% 
100% 
87.5% 
62.5% 
37.5% 
75.0% 
100% 
100% 
100% 
5.2.1.1.5. Blocking reagent 
Different blocking reagents have different attributes. While BSA tends to block even 
the true positive signals, blocking with casein has a high false-positive rate. Skim milk 
gave the best results. Table 5 showed the results of different blocking reagents used to 
block latex in concentration of 1% in Milli Q water reacted with 8 positive and 8 negative 
control sera. 
 
 
Table 5: Results of LAT using different blocking buffers. 
 
 
After skim milk had been chosen as blocking reagent, several concentrations of its buffer 
were tried to find out the best optimum one. Both Mill Q water and PBS were used to 
make different buffer media. At the end the best results were obtained with using 0.5% 
skim milk in MQ water as the blocking buffer. The results of the reaction of different 
dilution with 16 serum samples (8 positive and 8 negative) are shown in table 6. 
 
 
Table 6: Results of LAT using different dilutions of skim milk in Milli Q water and PBS. 
Abbreviations: MQ: Milli Q water obtained by specialized Millipore® system, PBS: phosphate buffer saline 
 
 
5.2.1.1.6. Blocking time 
One hour was decided to be the time for proper blocking. Shorter times, like 30 
minutes, reduce the blocking effect and therefore result in higher number of false 
agglutination. Longer tested times, as 2 and 5 hours, led to the inhibition of the weak 
signals that are produced by weak positive controls.  
 
5.2.1.1.7. Washing 
Blocking buffer True Positive 
Agglutination
True Negative 
Agglutination 
Sensitivity Specificity 
Sikm milk  
Bovine Serum Albumin 
Gelatin  
Casein  
Glycine  
7 
3 
4 
8 
4 
7 
8 
6 
3 
7 
87.5% 
37.5% 
50.0% 
100% 
50.0% 
87.5% 
100% 
75.0% 
37.5% 
87.5% 
Buffer 
medium 
Skim milk 
concentration 
True Positive 
Agglutination
True Negative 
Agglutination 
Sensitivity Specificity 
MQ water 
PBS 
MQ water 
PBS 
MQ water 
PBS 
MQ water 
PBS 
0.3% 
0.3% 
0.5% 
0.5% 
1% 
1% 
2% 
2% 
8 
6 
8 
5 
7 
2 
6 
1 
6 
7 
7 
8 
7 
8 
8 
8 
100% 
75.0% 
100% 
62.5% 
87.5% 
25.0% 
75.0% 
12.5% 
75.0% 
87.5% 
87.5% 
100% 
87.5% 
100% 
100% 
100% 
Only one step of washing, after blocking step, for one hour by a mixture of equal 
volumes of MQ water and the storage buffer (i.e. 1:2 storage buffer) was found to have 
minimum number of false results. 
 
5.2.1.1.8. Final Latex Suspension 
Different percentages of the final latex suspension resulted in different pictures. For 
example, in 1% latex suspension gave many weak agglutination signals. This may be 
attributed to the small number of latex particles which are not able to form strong clear 
agglutination. Eight percent latex suspension was also unable to produce good signal but 
this because of being very thick to get mixed properly with the serum sample. The best 
performance was obtained with latex suspension of 6%. 
 
5.2.1.1.9. Final test format 
5.2.1.1.9.1 Changing Serum : Latex ratio: None of the 3 tested ratio (1:2, 2:1 and 3:1) 
proved to be superior over the conventional 1:1. They added no 
advantages in the process of enhancing weak positive or removing false 
negative signals. 
5.2.1.1.9.2 Serum diluent and dilution: serum dilution was helpful to decrease the 
number of false agglutination reactions but it did so for the true ones also. 
That is to say dilution decreases the signal strength in either way. No 
significant improvement in the test outcome could be obtained by serum 
dilution neither by physiological saline nor by 0.1 M 2-mercaptoethanol. 
Results of reaction of several techniques, using different serum dilution 
and diluents, with 8 positive and 8 negative (4 of them constantly 
produced dales positive signals) control sera are shown in Table 7. 
 
Table 7: Results of LAT using different serum diluents and dilutions. 
Abbreviations: NS: normal saline, M: Molar, 2ME: 2-mercaptoethanol 
 
5.2.1.1.8.3.Serum inactivation: No significant effect could be observed between 
inactivated sera, by heating them to 60 °C for 5 minutes, and other ones 
regarding the test specificity.  
5.2.1.1.8.4.pH changing: Medium acidic pH increased the strength of agglutination 
while medium basic pH did the reverse. The results (Table 8) showed that 
addition of sodium carbonate did not eliminate all false positives and, in 
the same time, it reduced the strength of true positive signals. On the other 
hand, addition of hydrochloride also added no advantages for the test. 
Results of LAT on 8 positive and 8 negative (4 of them constantly 
Serum 
dilution 
Serum 
diluent  
True Positive 
Agglutination
True Negative 
Agglutination 
Sensitivity Specificity 
Undiluted 
1:2 
1:5 
1:2 
1:5 
- 
NS 
NS 
0.1 M 2ME 
0.1 M 2ME 
8 
7 
5 
7 
5 
4 
4 
6 
4 
6 
100% 
87.5% 
62.5% 
87.5% 
62.5% 
50.0% 
50.0% 
75.0% 
50.0% 
75.0% 
produced dales positive signals) serum samples using these modifications 
are shown in the Table 8. 
 
Table 8: Results of LAT with addition acid or bas in different dilutions. 
Abbreviations: M: Molar, HCl: Hydrochloride, NaCO4: Sodium carbonate 
 
 
5.2.1.1.10. Overall optimization results 
The best results were obtained with: 
1. Latex particles size, color and brands: 0.80 µm, Blue, ESTAPOR® 
2. Antigen: AE of soluble sonicate 
3. Antigen dilution: 1:5 in Milli Q water 
4. Coating time: 1 hour 
5. Blocking buffer: 0.5% skim milk in Mill Q water 
6. Blocking time: 1 hour 
7. Washing: one time in 1:2 storage buffer 
8. Final latex suspension: 6% 
9. Final test format: equal volumes of latex and serum (1:1) without any serum 
modification. 
 
 
5.2.1.2. Final Protocol 
 
After optimization steps, the best results  were obtained using 250 µl of acetone extract 
of the supernatant (with protein concentration of about 1.5 mg/ml) in dilution of 1:5 in 
MQ water to coat 250 µl of 3% 0.8 µm blue latex suspension (ESTAPOR®) for one hour 
over the magnetic stirrer. Then the particles were centrifuged at 13,200 x g and the 
supernatant was discarded. The pellet was resuspended in 500 µl MQ water and left over 
the magnetic stirrer to be washed for another hour. After centrifugation, the pellet was 
resuspended in 0.5% skim milk (DIFCO®) in MQ water for blocking during 1 hour.  The 
Latex particles were washed once more with MQ water. Finally the sensitized latex 
particles were resuspended in 125 µl of NaCl/Glycine buffer and to be ready for use. The 
test was performed by mixing 3µl of latex reagent with 3µl serum sample and rotating 
manually during 2 minutes after which the results were read..  
 
5.2.1.3. Plain Latex Results 
 
Serum 
dilution 
Acid / Base  True Positive 
Agglutination
True Negative 
Agglutination 
Sensitivity Specificity 
Undiluted 
1:2 
1:5 
1:2 
1:5 
 
- 
0.1M HCl 
0.1M HCl 
0.1M NaCO4 
0.1M NaCO4 
 
8 
7 
5 
7 
5 
4 
4 
6 
4 
6 
100% 
87.5% 
62.5% 
87.5% 
62.5% 
50.0% 
50.0% 
75.0% 
50.0% 
75.0% 
Table 9 below shows the results of 252 serum samples (107 positive and 145 negative) 
with the final format of optimized LAT. The test could detect 94.7% of East African sera 
but only 38% of sera from VL Brazilian patients showed positive agglutination signals. 
This led to decrease the overall test sensitivity (62.2%). Endemic controls show higher 
rates of false positive results than non endemic negative controls. No false positive results 
were obtained from the 5 serum samples of malaria patients. The overall specificity is 
89.7%. 
 
Table 9: The results of optimized LAT using plain latex on different serum groups. 
Abbreviations: CLB: serum of healthy Dutch personals obtained from central blood bank. 
* Patient from Brazil affected with other undetermined diseases than VL. 
 
 
5.2.2. Carboxylated latex 
 
5.2.2.1. Final Protocol 
 
Hundred microlitre of supernatant sonicate was coupled to 5 mg of 0.8 µm blue 
carboxyl-linked latex particles according to the company (BANG®) protocol. The test 
was performed in 2 formats;  
 
The first one is by mixing equal volume of latex and undiluted serum sample.  
 
 
 
The second one was performed by mixing 3 µl of serum with 3 µl PBS containing 10% 
skim milk (DIFCO®), then 3 µl latex reagent was added and mixed with the tip of a 
pipette. The results were read within one minute in both cases.  
 
5.2.2.2. Carboxylated latex Results 
Serum Group Total Positive 
Agglutination 
Negative 
Agglutination 
Sensitivity Specificity 
Serum
 group 
V
L sera (PC
) 
 
East African VL  
Brazilian VL   
Total  
57 
50 
107 
54 
19 
73 
3 
31 
34 
94.7% 
38.0% 
62.2% 
- 
- 
- 
H
ealthy and O
ther D
isease 
(N
C
) 
 
Healthy CLB   
Healthy East African  
Brazilian patients* 
Malaria 
Crohn’s 
Sarcoidosis  
Leptospirosis 
Other Dutch patients 
Total 
59 
21 
26 
5 
8 
7 
10 
9 
145 
3 
3 
3 
0 
2 
0 
2 
2 
15 
56 
18 
23 
5 
6 
7 
8 
7 
130 
- 
- 
- 
- 
- 
- 
- 
- 
- 
94.9% 
86.0% 
88.4% 
100% 
75.0% 
100% 
80.0% 
77.8% 
89.7% 
 
Both test format were tested using 28 positive and 32 negative control sera of different 
groups. In the first format (Table 10), both East African and Brazilian samples showed 
comparable sensitivities (unlike plain latex). The overall sensitivity is 89.2%. The 
specificity, however, was poor in all negative control serum groups with overall 
specificity of 43.8%. 
 
 
 Table 10: The results of the first test format of the LAT using carboxylated latex on 
different serum groups.  
Abbreviations: CLB: serum of healthy Dutch personals obtained from central blood bank. 
* Patient from Brazil affected with other undetermined diseases than VL. 
 
 
The results of second test format showed excellent overall specificity (100%) but with 
sensitivity of only 57.1%. Positive serum samples from East African VL patients showed 
slightly better sensitivity (62.5) than that of Brazilian ones (50%). The results of this 
format are shown in Table 11. 
 
 
 
 
 
 
 
 
 
 
Table 11: The results of the second test format of the LAT using carboxylated latex on 
different serum groups. 
Serum Group Total Positive 
Agglutination 
Negative 
Agglutination 
Sensitivity Specificity 
Serum
 group 
V
L sera (PC
) 
East African VL  
Brazilian VL   
Total  
16 
12 
28 
14 
11 
25 
2 
1 
3 
87.5% 
91.6% 
89.2% 
- 
- 
- 
H
ealthy and O
ther 
D
isease (N
C
) 
Healthy CLB   
Healthy East African  
Brazilian patients* 
Crohn’s 
Sarcoidosis  
Total 
8 
8 
8 
4 
4 
32 
4 
5 
5 
2 
2 
18 
4 
3 
3 
2 
2 
14 
- 
- 
- 
- 
- 
- 
50.0% 
37.5% 
37.5% 
50.0% 
50.0% 
43.8% 
Serum Group Total Positive 
Agglutination 
Negative 
Agglutination 
Sensitivity Specificity 
Abbreviations: CLB: serum of healthy Dutch personals obtained from central blood bank. 
* Patient from Brazil affected with other undetermined diseases than VL 
 
 
 
5.2.3. Magnetic beads 
 
5.2.3.1. Antigen 
 
None of the antigens could give satisfactory results when coupled to magnetic beads. 
Most of the tested negative control sera showed non specific agglutination. On the other 
hand, positive controls possessed different degree of weak agglutination signals. 
Modifications like changing antigen concentration and coating times were of no effects. 
Figure 4 below shows 6 positive and 6 negative control serum samples reacted with 
magnetic beads coated with SIR-2 recombinant antigen. It illustrates the difficulties of 
making clear distinction between positive and negative samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eight different antigens were used to coat magnetic beads according to the company 
(BANG®) protocol. Then equal volumes from the sensitized magnetic beads and serum 
Serum
 group 
V
L sera (PC
) 
East African VL  
Brazilian VL   
Total  
16 
12 
28 
10 
6 
16 
6 
6 
12 
62.5% 
50% 
57.1% 
- 
- 
- 
H
ealthy and O
ther 
D
isease (N
C
) 
Healthy CLB   
Healthy East African  
Brazilian patients* 
Crohn’s 
Sarcoidosis  
Total 
8 
8 
8 
4 
4 
32 
0 
0 
0 
0 
0 
0 
8 
8 
8 
4 
4 
32 
- 
- 
- 
- 
- 
- 
100% 
100% 
100% 
100% 
100% 
100% 
Figure 4:  
 
Agglutination assay using 
magnetic beads in 6 positive 
controls (A) and 6 negative 
controls (B).  
 
BA 
sample were used for the agglutination assay. Test results of 16 serum samples (8 
positive and 8 negative) are shown in Table 12. 
 
 
Table 12: Results of magnetic beads agglutination assay using 8 different antigens.  
Abbreviations: AE: Acetone extract, SIR-2: Silent regulatory-2 protein, DAT: direct agglutination test. 
 
 
5.2.3.2. Addition of anti human anti IgG magnetic particles 
 
Changing of the test format was tried by addition anti human anti IgG linked 1.5 µm 
magnetic particles (BANG®) to equal volume of serum and sensitized magnetic reagent. 
Magnetic beads were linked to 4 different antigens and tested in this format with 8 
positive and 8 negative control sera. Addition of anti human anti IgG magnetic beads 
generally resulted in slightly improvement of the test sensitivity using 2 antigens (100% 
instead of 87.5% for both soluble sonicate and AE of soluble sonicate antigens). It had, 
however, little effect on the specificity seen only in one antigen (37.5% instead of 25% 
for sediment sonicate). The results are shown in Table 13. 
 
 
Table 13: Results of magnetic beads agglutination assay using 4 different antigens with 
addition of anti human anti IgG magnetic particles. 
Abbreviations: AE: Acetones extract, SIR-2: Silent regulatory-2 protein 
 
 
5.3. Lateral Flow Assay 
 
5.3.1. Final Protocol 
 
Antigen 
 
True Positive 
Agglutination
True Negative 
Agglutination 
Sensitivity Specificity 
Soluble sonicate 
Sediment sonicate 
Mixed sonicate 
AE of soluble sonicate 
AE of sediment sonicate 
AE of intact promastigote 
SIR-2 
Modified DAT antigen  
7 
6 
7 
7 
7 
7 
7 
7 
1 
2 
1 
1 
1 
0 
2 
1 
87.5% 
75.0% 
87.5% 
87.5% 
87.5% 
87.5% 
87.5% 
87.5% 
12.5% 
25.0% 
12.5% 
12.5% 
12.5% 
0.0% 
25.0% 
12.5% 
Antigen 
 
True Positive 
Agglutination
True Negative 
Agglutination 
Sensitivity Specificity 
Soluble sonicate 
Sediment sonicate 
AE of soluble sonicate 
SIR-2 
8 
6 
8 
7 
1 
3 
1 
2 
100% 
75.0% 
100% 
87.5% 
12.5% 
37.5% 
12.5% 
25.0% 
After several steps of optimization (as described in 3.6.) and small panel testing, four 
different models were selected to undergo evaluation with larger panel of sera. Table 14 
shows these 4 models and describes their optimum condition. 
  
Table 14: The four selected test models for LaFT. 
 
Abbreviations: BSA: bovine serum albumin, PBS: phosphate buffer saline, PVA: polyvinyl alcohol, SIR2P: 
Silent regulatory-2 protein. 
 
5.3.2. Results 
 
No one of the four test models succeeded to produce sufficient sensitivity and 
specificity. It was clear that these two factors were alternating i.e. the test with high 
sensitivity had low specificity and vice versa. Some minor differences in the reaction 
patterns were observed between African and Brazilian serum samples. 
 
 
5.3.2.1. Model 1 
 
This model had a good sensitivity (90.9%) but it failed to discriminate 18 out of 22 
negative controls. It had the lowest specificity (18.2%) among the four models. Table 15 
shows the results of different sera tested by this model. 
 
 
 
 
 
 
 
 
Table 15: Results of LaFT using model 1. 
Model Antigen Dilution of 
Antigen 
Wicking 
Rate 
Blocking 
Buffer 
Gold 
Conjugate 
Optic 
Density 
Dilution Buffer 
1 
 
 
2 
 
 
3 
 
 
4 
Supernatant 
sonicate 
 
Supernatant 
sonicate 
 
Supernatant 
sonicate 
 
SIR2P 
Undiluted 
 
 
Undiluted 
 
 
1:2 
 
 
Undiluted 
 
180 
 
 
135 
 
 
135 
 
 
135 
Without 
 
 
Without 
 
 
1% PVA 
 
 
Without 
 
IgG 
 
 
IgG 
 
 
IgG 
 
 
IgG 
10 
 
 
10 
 
 
10 
 
 
5 
Milli Q water 
 
 
5%Tween 
20,5%BSA/PBS 
 
1.5%Tween20/ 
PBS 
 
5%Tween20,5%
BSA/PBS 
Serum Group Total Positive 
Signal 
Negative 
Signal 
Sensitivity Specificity
Abbreviations: CLB: serum of healthy Dutch  
 
 
5.3.2.2. Model 2 
 
Addition of BSA to the dilution buffer in this model leads to production of highly 
specific test. However, it has a negative drawback on the sensitivity (62.5%). The 
complete results are shown in Table 16. 
 
 
Table 16: Results of LaFT using model 2. 
Abbreviations: CLB: serum of healthy Dutch  
 
 
5.3.2.3. Model 5 
 
In this model, dilution of the supernatant sonicate antigen and reduction of the signal 
enhancer (Tween 20) resulted in specificity of 100%. While it could detect 80% of the 
Brazilian samples, only 3 out of 8 East African samples showed positive signals. The 
lowest sensitivity among all models was reported in this one. The results are shown in 
Table 17. 
 
Table 17: Results of LaFT using model 3. 
Serum
 group 
V
L sera 
(PC
)
East African VL  
Brazilian VL   
Total  
10 
12 
22 
8 
12 
20 
2 
0 
2 
80% 
100% 
90.9% 
- 
- 
- 
H
ealthy and 
O
ther D
isease 
(N
C
)
Healthy CLB   
Brazilian patients 
with other diseases 
Total 
10 
12 
 
22 
2 
2 
 
4 
8 
10 
 
18 
- 
- 
- 
20% 
16.7% 
 
18.2% 
Serum Group Total Positive 
Signal 
Negative 
Signal 
Sensitivity Specificity
Serum
 group 
V
L sera 
(PC
)
East African VL  
Total  
16 
16 
10 
10 
6 
6 
62.5% 
62.5% 
- 
- 
H
ealthy and 
O
ther D
isease 
(N
C
)
Healthy CLB   
Other diseases 
Total 
8 
8 
16 
0 
0 
0 
8 
8 
16 
- 
- 
- 
100% 
100% 
100% 
Serum Group Total Positive 
Signal 
Negative 
Signal 
Sensitivity Specificity
Abbreviations: CLB: serum of healthy Dutch  
 
 
5.3.2.4. Model 4 
 
In this model, SIR2 recombinant antigen was used. It scored the best sensitivity (100%) 
over all other tested models. Specificity was 80% in sera collected from non-endemic 
patients with other diseases than VL. On the other hand, the test showed false positive 
signals with all sera from Brazilian patients with other diseases. The overall specificity 
was poor (30.8%). Results are shown in Table 18. 
 
 
Table 18: Results of LaFT using model 4. 
Abbreviations: CLB: serum of healthy Dutch  
 
 
 
 
 
 
Serum
 group 
V
L sera 
(PC
)
East African VL  
Brazilian VL 
Total  
8 
5 
13 
3 
4 
7 
 
5 
1 
6 
37.5% 
80% 
46.2% 
- 
- 
H
ealthy and 
O
ther D
isease 
(N
C
)
Healthy CLB   
Brazilian Patients 
with other diseases 
Other diseases 
Total 
2 
11 
 
2 
15 
0 
0 
 
0 
0 
2 
11 
 
2 
16 
- 
- 
- 
100% 
100% 
 
100% 
100% 
Serum Group Total Positive 
Signal 
Negative 
Signal 
Sensitivity Specificity
Serum
 group 
V
L sera 
(PC
)
East African VL  
Brazilian VL 
Total  
5 
8 
13 
5 
8 
13 
 
0 
0 
0 
100% 
100% 
100% 
- 
- 
H
ealthy and 
O
ther D
isease 
(N
C
)
Brazilian Patients 
with other diseases 
Other diseases 
Total 
8 
 
5 
13 
8 
 
1 
9 
0 
 
4 
4 
- 
 
- 
- 
0% 
 
80% 
30.8% 
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6. Discussion 
 
6.1. Agglutination assay: 
 
6.1.1. Plain latex: 
 
In this study, LAT based on plain latex showed overall sensitivity of 62.2% which is far 
lower than those reported by Cummins et al, 1994 (93%) and Moody and El Safi (88%). 
This perhaps can be explained by the different natures of the serum samples used in the 
different studies. The two previous studies used sera of VL patients from Sudan while in 
this study sera from Brazilian patients were included beside those from Sudan and Kenya. 
The final format of sensitized plain latex used in this study was able to detect 94.7% of 
the African VL sera. This figure is slightly higher than sensitivity figures reported in both 
previous studies. However, only 38% of the serum samples of VL patients from Brazil 
gave positive results. This huge difference is very difficult to be explained since the two 
groups were proven positive by both parasitology and DAT. The letter test is based on an 
antigen formed from the same strain of Leishmania donovani used to prepare the 
different antigens applied in this study. Brazilian samples react perfectly with the DAT 
antigen and therefore it is less likely for the parasite species to be the cause of the 
different reaction patterns observed between Brazilian and East African group. Such a 
difference in behavior between these two groups was also observed among other tests 
like rK39 dipstick which results in a regional limitation of its usage (Schallig et al., 
2002). 
 
The overall specificity of 89.7% is lower than that obtained by Cummins et al., 1994 
(100%) but slightly higher than that of Moody and El Safi (88%). The heterogeneity of 
the several groups of negative controls studied beside the large number of tested samples 
could be responsible for the lower specificity. This specificity is lower than that of DAT 
(95-100%) (Zijlistra and El Hassan, 2001) but is comparable to that of rK39 (91.8%) 
(Boelaert et al., 2008). In addition, both test sensitivity and specificity are comparable to 
other latex agglutination-based diagnostic tests for Neisseria meningitides (sensitivity 
88%, specificity 93%) (Borela et al., 2006), typhoid fever (sensitivity 84.6%, specificity 
96.6%) (Abdoel et al., 2007) and avian influenza (sensitivity 88.8%, specificity 97.9%) 
(Yu et al., 2006). However, many other LATs performs better than this test like that 
which developed for detection of Trypanosoma brucei gambiense antibodies in the 
cerebrospinal fluid of infected patients (Buscher et al., 1999). This test achieved 
specificity of 99% and it sensitivity ranged between 83.8 and 100% depending on the 
geographical origin of the sample. 
 
Although the final protocol was optimized using acetone extract of the sonicate 
supernatant as the coating antigen, other different antigens also did work. In fact, late 
experiments proved no significant differences in the out come when the protocol is 
applied on the following antigens (data not shown): 
1. Acetone extract of the sonicate supernatant. 
2. Acetone extract of the sonicate sediment. 
3. Acetone extract of the whole promastigote. 
4. Supernatent sonicate. 
5. Recombinant SIR2 protein. 
6. Supernatent of solubilized freeze-dried DAT antigen. 
 
Since these antigens are related to different groups, they were expected to behave 
differently and therefore they should have different outcomes. Because of this illogical 
similarity, effort were spent to figure out the real cause of agglutination. The prepared 
culture medium, which was used to grow the parasite, was used to coat latex particles 
according to the final protocol. Surprisingly, the results were almost the same as other 
antigens. On the last experiment, the latex particles just washed by MQ water before 
blocking and washing steps. Again, the result came as perfect as the selected antigen. 
 
No one logical explanation can explain this harsh picture. It is quite normal for washed 
latex particles to give non specific agglutination with the vast majority of serum samples. 
This is due to the difference of electrical gradient between the serum proteins and the 
uncoated surfaces of latex particles (Schulz and Sticher, 1994). However, the fact that 
these latex particles are being able to give specific reaction, after blocking and washing, 
with VL sera only is not understandable. The possibility of contamination of the major 
latex block was excluded by trying different brands of the same latex size (0.8 µm, Blue, 
SIGMA®) according to the final protocol. Two main hypothesis were put to explain this 
feature.  
 
The first hypothesis: “The very high levels of IgG which is usually occurred in 
the sera of VL patients might be able to attract latex particle even without being 
coated with a specific antigen. This attraction will ultimately lead to 
agglutination”.  This, in fact, the principle of the formol gel test which detect the 
greatly increased serum proteins and immunoglobulin in VL which is carried out 
by addition of one drop of full-strength formalin to 1 ml of serum, with rapid and 
complete coagulation indicating the positive reaction (Zijlistra and El Hassan, 
2001). The possibility that the current LAT behave similarly to the formol gel test 
is considered, however, some facts are against this hypothesis. First of all, most of 
the sera of VL patients for Brazil did not show any agglutination despite the fact 
that most of them have very high DAT titer. Secondly, the 3 East African VL sera 
which scored negative in this agglutination assay, all of them had DAT titer more 
than 102,400. Thirdly, reacting pure human IgG (SIGMA®) with the latex 
revealed no agglutination. 
 
The second hypothesis: “The skim milk is responsible for the agglutination 
because of possible sharing of similar parasite epitopes”. This hypothesis might 
explain why the agglutination reaction is mostly seen with VL sera. By saying 
that this “possible epitopes” are not common in the new world form of the 
disease, it can also explain why such a reaction is seen rarely with the Brazilian 
VL sera. Again, it can justify why blocking with other blocking reagents like 
BSA, glycine and gelatin gave far lower values of sensitivity as shown in table 5. 
 
Regardless the true explanation for this feature, the test seemed to react in a non 
specific matter. This means that the agglutination which it produced with VL sera is not 
due to an immunological interaction between particular parasite antigens and specific 
antibodies. Lacking of a solid scientific base makes the outcomes of the current test 
format quite unpredictable. Despite its accurate performance on East African sera, such a 
test is not reliable to undergo Phase II evaluation. 
 
 
6.1.2. Carboxylated latex 
 
The most important advantage of CL over the plain latex is being able to react with 
Brazilian VL sera as well as the East African ones. Two important problems were faced 
during the optimization process of this type of latex. The first one was the weak easily 
disrupted signals. To overcome this problem, no rotation was done after mixing. The 
second problem was the high number of false agglutination with negative control sera. 
On early experiments, CL was able to pick 11 out of 12 Brazilian VL sera. However, 9 
out of 16 of negative control sera showed agglutination as well. Neither blocking, 
dilution of the antigen nor dilution of the serum sample could be able to improve the 
specificity. 
 
The final format of the test, which compromise direct mixing of a blocking reagent with 
the serum, revealed excellent specificity but with very poor sensitivity of 57%. 
Unfortunately, the time was not sufficient for trying other modifications. LAT based on 
carboxylated latex particles was previously developed for diagnosis of various medical 
and veterinary usages. Bhaskar et al., 2003 developed and evaluated LAT, using 
carboxylated latex, for diagnosis of pulmonary tuberculosis with good sensitivity and 
specificity of 94% and 92.2% respectively. However, some other studies reported lower 
figures of sensitivity and specificity like the LAT developed for avian influenza which 
gave sensitivity of 82% and specificity of 86.5% (Zhengjun et al., 2006).  It is clear that 
the carboxylated latex agglutination performance depend grossly on the nature of antigen 
and the nature of the antibodies produced by a particular disease (Nakamura et al., 1992). 
 
The initial low figures of specificity for LAT using CL can be explained by the process 
of coupling itself. A direct chemical bond is formed between the carboxyl group on latex 
particles’ surface and a functional group at any residue of the antigen (Baglioni et al., 
1987). To limit the variability of the binding site, most of the available agglutination 
assay based on CL use pure antigens for coupling. Using of sonicate supernatant which 
contains high numbers of different proteins for this type of particles will most probably 
lead to poor specificity. This conclusion is supported by the more specific results which 
were obtained using SIR2 recombinant protein. By using this antigen, 7 out of 10 
negative control sera scored negative. However, only 9 serum sample out of 16 VL sera 
gave agglutination signals. This outcome might be improved by increasing the antigen 
concentration through increasing its amount used for coupling. Unfortunately this was not 
possible because of the limited received amount of the antigen. 
 
 
6.1.3. Magnetic beads 
 
Despite all methods that had been tried, magnetic beads failed to show satisfactory 
results. Addition of Antihuman Anti IgG to the assay was not helpful. The main problem 
with the using of MB reagents was the agglutination-like picture that they usually 
produced regardless the type of sera. This is perhaps attributed to the relative huge size 
(3.0 µm) of the MB particles. Many MB-based agglutination assay were developed to 
diagnose a variety of diseases like human immunodeficiency virus (HIV) infection 
(Workman et al., 2009), Human T-lymphotropic virus 1 (HTLV-1) infection (Sohma et 
al., 1995). Most of these assays used specialized devices like magnetic assay reader 
(Namba et al., 1991) and turbidimeter (Baudry et al., 2006) to read test results. These 
technologies are not convenient for this project because of the difficulties of their field 
application. 
 
 
6.2. Lateral Flow: 
 
Again specificity was the main problem during the development of this test. Negative 
control groups show different behavior on testing with lateral flow assay. While CLB 
sera from Dutch healthy personnel almost always gave clear negative results, Brazilian 
patient sera had much potential to give false positive results. The reaction of sera from 
healthy Dutch population, who had not been to an endemic field differ substantially from 
that of sera from health people in VL endemic area. Blocking was tried to overcome this 
problem but it often resulted in decreasing in the intensity of the false signals rather than 
abolishing. In addition, it reduces the sensitivity. Modification of the dilution buffer was 
of little effect. These observations indicate the need for more specific antigen which can 
distinct the later group clearly from VL patients. 
The balance between sensitivity and specificity in LaFT represents a great challenge for 
test developers. The difficulties arises from the huge number the variable materials and 
techniques that need to be optimized. Nevertheless, the antigen remains the most 
important one. One study reported 100% sensitivity and specificity of a LaFT for 
detecting and measuring anti-Anthrax immuno globulin (Biagini et al., 2006). However, 
the more common case is to have unbalanced between sensitivity and specificity. Slinger 
et al., (2004) reported 100% specificity but only a sensitivity of 80% in their LaFT for 
respiratory syncytial virus (RSV) detection. Similar results were seen in LaFT for 
diagnosis of dengue fever with sensitivity of 72.8% and specificity of 100 % (Hang et al., 
2009). In contrast, LaFT for leprosy diagnosis gave sensitivity of 97.4% and specificity 
of only 86.2% (Bührer-Sékula et al., 2003). 
 
 
 
 
 
 
 
 
7. Conclusions 
 
 
The following outcomes can be concluded from this study: 
 
1. With the current standing, neither the 3 different types of the agglutination assays 
nor the LaFT fulfilled the requirements for phase I development. All tests were 
inferior to the DAT. 
 
2. LAT using plain latex shows good performance on African VL sera. However, it 
has got a fundamental problem regarding its specificity since there was no 
difference in the reaction with sera between coated and uncoated particles. The 
exact cause for this phenomenon could not been determined. The fact that the 
agglutination was seen only an East African sera and not with sera from Brazil is 
difficult to explain.  
 
3. The ability of being able to react with Brazilian sera was an important advantage 
of LAT based on carboxylated latex particles. However, no one of the optimized 
two final format could be able to provide accurate test. 
 
4. Agglutination assay based on magnetic beads could not be developed to produce 
satisfactory results in simple test format. More complicated tools perhaps may be 
useful to improve the performance of this test but they are not convenient for field 
diagnosis. 
 
5.  None of the different models of optimized LaFT used in this study had sufficient 
sensitivity and specificity. The antigens used perhaps were not good enough for 
this particular assay. 
 
 
 
 
 
 
 
 
 
 
 
 
8. Recommendations 
 
Setting up simple accurate diagnostic tests for VL for field use still remains a priority 
for treatment and control measures. To achieve this, some recommendations are 
suggested for further studies: 
 
1. Focusing on East African sera only: 
Many differences between East African and Brazilian sera were seen through out this 
study. Brazilian VL sera did not react well with the final latex format unlike Sudanese 
VL sera. On the other hand, negative control sera from Brazil showed very high rate of 
false passivity on the lateral flow assay compared to other negative control groups. This 
difference was seen in many previous studies regarding the rK39 dipstick 
 
2. Using a specific antigen: 
One of the most important characteristics of VL is the production of huge amount of 
antibodies. This is attributed to the large amount of immunogenic antigens found in the 
parasite. Some of these antigens are also found on other pathogens which are responsible 
for other diseases. This probably can explain the low values of specificity that were 
shown in this study, particularly in lateral flow test. 
 
3. More basic evaluation of the candidate antigens: 
This study showed clearly that the antigen which works perfectly on ELISA is not 
always going to do so on rapid diagnostic assays. The several washing steps and the long 
incubation time in ELISA are probably the responsible factors for this difference. There 
are more than 10 different antigens used for diagnostic VL ELISA (Maalej et al., 2003). 
At least 6 of them gave almost similar results of very high sensitivity and specificity 
figures. These antigens are of different natures. Some of them are  recombinant proteins 
and some others are purified protein. There are also different carbohydrate fragments, 
most important LPG. Each one of these antigen can act as a possible candidate to be used 
in a rapid diagnostic assay. 
 
4. Exploring other options:   
The advantages of serological methods are being direct and easier to be set up. 
However, they have some disadvantages such as remaining positive for long time after 
the eradication of infection and detecting the subclinical form of the disease. The 
possibility of development of simple diagnostic tests based on other bases than antibodies  
detection, like antigen or nucleic acid detection, should be investigated.  
 
 
 
 
 
 
 
 
 
9. References 
 
Abdalla R. E. (1980). Serodiagnosis of visceral leishmanisis in an endemic area of the Sudan. 
Ann. of Trop. Med. & Parasitol., 74:  415-419. 
Abdallah K. A., Nour B. Y., Schallig H. D., Mergani A., Hamid Z., Elkarim A. A., Saeed O. 
K. and Mohamadani A.A. (2004). Evaluation of the direct agglutination test based on 
freeze-dried Leishmania donovani promastigotes for the serodiagnosis of visceral 
leishmaniasis in Sudanese patients. Trop Med Int Health., 9(10):1127-1131. 
Abdel-Hameed A. A., El Harith A. E. and Abdel-Rahim I. M. (1989). Potential of a direct 
agglutination test (DAT) for detection of visceral leishmaniasis in a known endemic area 
in Sudan. Trop Med Parasitol., 40(4):470-471. 
Abdel-Hameed A. A. (1993). Spleen puncture for the diagnosis of visceral leishmaniasis. 
Trans R Soc Trop Med Hyg., 87(5):607-808. 
Abdoel T. H. and Smits H. L. (2007). Rapid latex agglutination test for the serodiagnosis of 
human brucellosis.  Diagn Microbiol Infect Dis. 57(2):123-128. 
Abdus Salam M., Mondal D., Kabir M. and Haque R. (2009). rK39 enzyme-linked 
immunosorbent assay for the diagnosis of kala-azar in an endemic zone of Bangladesh. 
Pak J Med Sci, 25(4): 635-640. 
Abramo C., Fontes C. J. and Krettli A. U. (1995). Cross-reactivity between antibodies in the 
sera of individuals with leishmaniasis, toxoplasmosis, and Chagas' disease and antigens 
of the blood-stage forms of Plasmodium falciparum determined by indirect 
immunofluorescence. Am J Trop Med Hyg., 53(2):202-205. 
Adhya S., Chatterjee M., Hassan M. Q., Mukherjee S. and Sen S. (1995). Detection of 
Leishmania in the blood of early kala-azar patients with the aid of the polymerase chain 
reaction. Trans R Soc Trop Med Hyg., 89(6):622-624. 
Adini I., Jacobson R. L., Kasap M., Schlein Y. and Jaffe C. L. (2004). Species-specific 
detection of Leishmania in sandflies using an enzyme-linked immunosorbent assay. 
Trans R Soc Trop Med Hyg., 92(1):35-37. 
Adler S., Foner A. and Montiglio B. (1966). The relationship between human and animal 
strains of Leishmania from the Sudan. Trans R Soc Trop Med Hyg., 60:380-386. 
Ahluwalia I. B., Bern C., Costa C., Akter T., Chowdhury R., Ali M., Alam D., Kenah E., 
Amann J., Islam M., Wagatsuma Y., Haque R., Breiman R. F., Maguire J. H. (2003). 
Visceral leishmaniasis: consequences of a neglected disease in a Bangladeshi community. 
Am J Trop Med Hyg., 69(6):624-628. 
Ahmed M. A., Suleman S. M., Kordofani A. Y. and Mustafa M. D. (1988). Outbreak of 
visceral leishmaniasis in the western bank of the White Nile-Sudan, report and clinical 
study. East African Med.l J., 65:824-828. 
Aleixo J. A., Nascimento E. T., Monteiro G. R., Fernandes M. Z., Ramos A. M., Wilson M. 
E., Pearson R. D. and Jeronimo S. M. (2006). Atypical American visceral leishmaniasis 
caused by disseminated Leishmania amazonensis infection presenting with hepatitis and 
adenopathy. Trans R Soc Trop Med Hyg., 100(1):79-82. 
Allain D. S. and Kagan IG. (1975). A direct agglutination test for leishmaniasis. Am J Trop 
Med Hyg., 24(2):232-236. 
Alliluev P. , Koroleva I. S. , Vengerov Y. Y. , Kotel'nikova O. V. , Medvedeva N. V. , 
Kharitonova A. V. and Yashina N. V.  (1999). Latex agglutination test for rapid and 
retrospective diagnosis of meningococcal infection. Bull. of Experim. Bio. and Med., 
128(5): 1128-1131. 
Alvar, J., Cañavate C.,. Gutiérrez-Solar B, Jiménez M., Laguna F., López-Vélez R., Molina 
R. and Moreno J. (1997). Leishmania and human immunodeficiency virus coinfection: 
the first 10 years. Clin. Microbiol. Rev. 10: 298-319. 
Aoun K., Ben Romdhane N., Bouratbine A. and Limam F. (2002). [Isolated adenopathy in 
leishmaniasis due to Leishmania infantum]. Presse Med., 31(40):1890-1892. 
Andresen K., Gasim S., Elhassan A. M., Khalil E. A., Barker D. C., Theander T. G. and 
Kharazmi A. (1997). Diagnosis of visceral leishmaniasis by the polymerase chain 
reaction using blood, bone marrow and lymph node samples from patients from the 
Sudan. Trop Med Int Health., 2(5):440-444. 
Ashford R. W., Desjeux P., Deraadt P. (1992). Estimation of populations at risk of infection 
with leishmaniasis. Parasitol Today 8: 104-105. 
Archibald R. G. (1914). A preliminary report on some further investigations on kala-azar in 
the Sudan. J R Army Med Corp, 23:479-495. 
Archibald R. G. (1923). Kala-azar in the Sudan with special reference to its treatment with 
tartar emetic. Am J Trop Med Hyg., 3: 307-324. 
Attar Z. J., Chance M. L., El Safi S., Carney J., Azazy A., El-Hadi M., Dourado C., Hommel 
M. (2001). Latex agglutination test for the detection of urinary antigens in visceral 
leishmaniasis. Acta Tropica, 78: 11-16. 
Babiker O. E., Davidson R., Mazinda C., Kipnngetich S., and Ritmeijer K. (2007). Utility of 
lymph node aspiration in the diagnosis of visceral leishmaniasis in Sudan. Am. J. Trop. 
Med. Hyg., 76(4): 689-693. 
Badaro R., Reed S. G. and Carvalho E. M. (1983). Immunofluorescent antibody test in 
American visceral leishmaniasis: sensitivity and specificity of different morphological 
forms of two Leishmania species. Am J Trop Med Hyg., 32(3):480-484. 
Badaro R., Benson D., Eulálio M. C., Freire M., Cunha S., Netto E. M., Pedral-Sampaio D., 
Madureira C., Burns J. M., Houghton R. L., David J. R., Reed S.G. (1996). rK39: a 
cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect 
Dis., 173(3):758-761. 
Baglioni P., Cocciaro R. and Dei L. (1987). Surface properties of carboxylate latex particles. 
J. Phys. Chem., 91(15): 4020–4023. 
Barker D. C. and Butcher J. (1983). The use of DNA probes in the identification of 
Leishmanias: discrimination between isolates of the Leishmania mexicana and L. 
braziliensis complexs. Trans R Soc Trop Med Hyg.,  77: 285-297.  
Baudry J., Rouzeau C., Goubault C., Robic C., Cohen-Tannoudji L., Koenig A., Bertrand E. 
and Bibette J. (2006). Acceleration of the recognition rate between grafted ligands and 
receptors with magnetic forces. PNAS, 103(44): 16076-16078. 
Bhaskar S., Banavaliker J. N., and Hanif M. (2003). Large-scale validation of a latex 
agglutination test for diagnosis of tuberculosis. FEMS Immunol Med Microbiol., 
39(3):235-239. 
Biagini R.E., Sammons D. L., Smith J. P., MacKenzie B. A., Striley C. F., Snawder J. E., 
Robertson S. A. and Quinn C. P. (2006). Rapid, Sensitive, and Specific Lateral-Flow 
Immunochromatographic Device To Measure Anti-Anthrax Protective Antigen 
Immunoglobulin G in Serum and Whole Blood. Clinic. and Vaccine Immuno.,  13(5): 
541-546. 
Blum J., Desjeux P., Schwartz E., Beck B., Hatz C. (2004). Treatment of cutaneous 
leishmaniasis among travellers. J Antimicrob Chemother, 53(2):158-166. 
Boelaert M., El Safi S., Mousa H., Githure J., Mbati P., Gurubacharya V., Shrestha J., 
Jacquet D., De Muynck A., Le Ray D. and Van der Stuyft P. (1999a). Multi-centre 
evaluation of repeatability and reproducibility of the direct agglutination test for visceral 
leishmaniasis. Trop Med Int Health., 4(1):31-37. 
Boelaert M., El Safi S., Jacquet D., de Muynck A., van der Stuyft P. and Le Ray D. (1999b). 
Operational validation of the direct agglutination test for diagnosis of visceral 
leishmaniasis. Am J Trop Med Hyg., 60(1):129-134. 
Boelaert M., Rijal S., Regmi S., Singh R., Karki B., Jacquet D., Chappuis F., Campino L., 
Desjeux P., Le Ray D., Koirala S. and Van der Stuyft P. (2004) A comparative study of 
the effectiveness of diagnostic tests for visceral leishmaniasis. Am J Trop Med Hyg., 
70(1):72-77. 
Boelaert M., Bhattacharya S., Chappuis F., El Safi S. H., Hailu A., Mondal D., Rijal S., 
Sundar S., Wasunna M., Peeling R. W. (2007) Evaluation of rapid diagnostic tests: 
visceral leishmaniasis, Nature reviews: microbiology, 5(11): S30-S39 
Boelaert M., El Safi S. H., Hailu A., Mukhtar M., Rijal S., Sundar S., Wasunna M., Aseffa 
A., Mbui J., Menten J., Desjeux P., Peeling R. W. (2008). Diagnostic tests of Kala-azar: a 
multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and 
the Indian subcontinent. Trans R Soc Trop Med Hyg.,  102: 32-40. 
Bora D. (1999). Epidemiology of visceral leishmaniasis in India. Natl. Med. J. India, 12:62-
68. 
Borela T., Rosea A. C., Guillermb M., Sidikouc F., Gerstl a S., Djibod A., Nathana N., 
Chanteauc S. and Guerina P. J. (2006). High sensitivity and specificity of the Pastorex® 
latex agglutination test for Neisseria meningitides serogroup A during a clinical trial in 
Niger. Trans R Soc Trop Med Hyg., 100:964-969. 
Bossolasco S., Gaiera G., Olchini D., Gulletta M., Martello L., Bestetti A., Bossi L., 
Germagnoli L., Lazzarin A., Uberti-Foppa C. and Cinque P. (2003). Real-time PCR assay 
for clinical management of human immunodeficiency virus-infected patients with 
visceral leishmaniasis. J Clin Microbiol., 41(11):5080-5084. 
Bretagne S., Durand R., Olivi M., Garin J. F., Sulahian A., Rivollet D., Vidaud M. and 
Deniau M. (2001). Real-time PCR as a new tool for quantifying Leishmania infantum in 
liver in infected mice. Clin Diagn Lab Immunol., 8(4):828-831. 
Bührer-Sékula S., Smits H. L., Gussenhoven G. C., van Leeuwen J.,  Amador S., Fujiwara T., 
Klatser P. R., and Oskam L.  (2003). Simple and fast lateral flow test for classification of 
leprosy patients and identification of contacts with high risk of developing leprosy. J Clin 
Microbiol., 41: 1991-1995. 
Burns J. M., Ssreffler W. G., Benson D. R., Ghalib H.W., Badaro R. and. Reed S. G (1993). 
Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects 
specific antibody in African and American visceral leishmaniasis. Medical Sciences, 90: 
775-779. 
Buscher P., Lejon V., Magnus E. and Van Meirvenne N. (1999). Improved latex 
agglutination test for detection of antibodies in serum and cerebrospinal fluid of 
Trypanosoma brucei gambiense infected patients. Acta Tropica, 73(1): 11-20. 
Carvalho S. F., Lemos E. M., Corey R. and Dietze R. (2003). Performance of recombinant 
K39 antigen in the diagnosis of Brazilian visceral leishmaniasis. Am J Trop Med Hyg., 
68(3):321-324. 
Chappuis F., Mueller Y., Nguimfack A., Rwakimari J. B., Couffignal S., Boelaert M., 
Cavailler P., Loutan L. and Piola P. (2005). Diagnostic accuracy of two rK39 antigen-
based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in 
northeastern Uganda. J Clin Microbiol., 43(12):5973-5977. 
Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R. W., Alvar J. and Boelaert 
M. (2007). Visceral leishmaniasis: what are the needs for diagnosis, treatment and 
control? Nat Rev Microbiol., 5(11):873-882. 
Chatterjee P., Pezzuto J. M. and Kouzi S. A. (1999). Glucosidation of betulinic acid by 
Cunninghamella species. J Nat Prod., 62(5): 761-763. 
Chulay J. D. and Bryceson A. D. (1983). Quantitation of amastigotes of Leishmania 
donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am. J. 
Trop. Med. Hyg., 32:475-479. 
Cole A. E., Cosgrove P. C. and Robinson G. (1942). A preliminary report of an outbreak of 
kala-azar in a battalion of King’s African Rifles. Trans R Soc Trop Med Hyg., 36:25-34.  
Cerf B. J., Jones T. C., Badaro R., Sampaio D., Teixeira R. and Johnson W. D. Jr. (1987). 
Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis., 156(6):1030-
1033. 
Cummins A. J., Moody A. H., Lalloo K. and Chiodini P. L. (1994). Development of a rapid 
latex agglutination test for the detection of visceral leishmaniasis. Trans R Soc Trop Med 
Hyg.,  88: 300. 
Cupolillo E., Medina-Acosta E., Noyes H., Momen H. and Grimaldi Jr G. (2000). A revised 
classification for Leishmania and Endotrypanum. Parasitol Today 16: 142-144.   
da Silva M. R., Stewart J. M. and Costa C. H. (2005). Sensitivity of bone marrow aspirates in 
the diagnosis of visceral leishmaniasis. Am J Trop Med Hyg., 72(6):811-814. 
Das V. N., Pandey K., Verma N., Lal C. S., Bimal S., Topno R. K., Singh D., Siddiqui N. A., 
Verma R.B. and Das P. (2009). Short report: Development of post-kala-azar dermal 
leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis. Am J Trop Med Hyg., 
80(3):336-338. 
De Beer P., Harith A., Deng L. L., Semiao-Santos S. J., Chantal B. and Van Grootheest M. 
(1991). A killing disease epidemic among displaced Sudanese population identified as 
visceral leishmaniasis. Am J Trop Med Hyg., 44(3):  283-289. 
De Doncker S., Hutse V., Abdellati S., Rijal S., Singh Karki B. M., Decuypere S., Jacquet 
D., Le Ray D., Boelaert M., Koirala S. and Dujardin J. C. (2005). A new PCR-ELISA for 
diagnosis of visceral leishmaniasis in blood of HIV-negative subjects. Trans R Soc Trop 
Med Hyg., 99(1):25-31. 
De Gorgolas M. and Miles M. A. (1994). Visceral leishmaniasis and AIDS. Nature. 
372(6508): 734. 
Diro E., Techane Y., Tefera T., Assefa Y., Kebede T., Genetu A., Kebede Y., Tesfaye A., 
Ergicho B., Gebre-Yohannes A., Mengistu G., Engers H., Aseffa A., Desjeux P., Boelaert 
M and Hailu A. (2007). Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine 
latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia. Trans R 
Soc Trop Med Hyg., 101(9):908-914.  
Duarte M. I., Mariano O. N. and Corbett C. E. (1989). Liver parenchymal cell parasitism in 
human visceral leishmaniasis. Virchows Arch A Pathol Anat Histopathol., 415(1):1-6. 
Eapen C. K., Sugathan S., Kuriakose M., Abdoel T. and Smits H. L.  (2002). Evaluation of 
the clinical utility of a rapid blood test for human leptospirosis diagnosis. Diagn 
Microbiol Infect Dis., 42: 221-225. 
El Amin  E. R. M.. Wriaht E. P., Abdel Rahman A. M.. Kolk A., Laarman J. and Pondman 
K. W. (1986). Serodiagnosis of Sudanese visceral and mucosal leishmaniasis: 
comparison of ELISA-immunofluorescence and indirect haemagglutination. Trans R Soc 
Trop Med Hyg., 80:271-274. 
Eldaw A. and Khalfan H. A. (1988). Aminomethyl coumarin acetic acid and fluorescein 
isothiocyanate in detection of leishmanial antibodies: a comparative study. Trans R Soc 
Trop Med Hyg., 82(4):561-562. 
El Hassan A. M., Hashim F. A., Siddig Ali, M., Ghalib, H. W. and Zijlstra, E. E. (1993a). 
Kala-azar in western Upper Nile in the southem Sudan and its spread to a nomadic tribe 
from the north. Trans R Soc Trop Med Hyg., 87:395-398. 
El Hassan A. M., Zijlstra E. E., Meredith S. 0. and Ismail A. (1993b). Identification of 
Leishmania donovani using a polymerase chain reaction in patient and animal material 
obtained from an area of endemic kala-azar in the Sudan. Acta Tropica, 55:87-90. 
El Hassan A. M. and Khalil E. A. (2001). Post-kala-azar dermal leishmaniasis: does it play a 
role in the transmission of Leishmania donovani in the Sudan? Trop Med Int Health., 
6(9):743-744. 
El Harith A. E., Kolk A. H., Kager P. A., Leeuwenburg J., Muigai R., Kiugu S. and Laarman 
J. J. (1986). A simple and economical direct agglutination test for serodiagnosis and sero-
epidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg., 
80(4):583-636. 
El Harith A., Laarman J. J., Minter-Goedbloed E., Kager P. A. and Kolk A. H. (1987). 
Trypsin-treated and coomassie blue-stained epimastigote antigen in a microagglutination 
test for Chagas' disease. Am J Trop Med Hyg., 37(1):66-71. 
El Harith A. E., Kolk A. H., leeuwenberg J., Muigia R., Huigen E., Jelsma T. And Kager P. 
A. (1988). Improvement of a direct agglutination test for field studies of visceral 
leishmaniasis. J Clin Microbiol., 33: 1984-1988. 
Elnaiem D. A., Connor S. J., Thomson M. C., Hassan M. M., Hassan H. K., Aboud M. A. 
and Ashford, R. W. (1998). Environmental determinants of the distribution of 
Phlebotomus orientalis in Sudan. Ann. of Trop. Med. and Parast., 92: 877-887. 
El Safi S. H. and Evans D. A. (1989). A comparison of the direct agglutination test and 
enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan. 
Trans R Soc Trop Med Hyg.,  83: 334-337. 
El Safi S. H., Peters W. and Evans D. A. (1991). Studies on the leishmaniasis in the Sudan. 
3.Clinical and parasitological studies of visceral and mucosal leishmaniasis. Trans R Soc 
Trop Med Hyg.,  85: 465-470. 
El Safi S. H., Bucheton B., Kheir M. M., Musa H. A., EL-Obaid M.,  Hammad A. and 
Dessein A. (2002). Epidemiology of visceral leishmaniasis in Atbara River area, eastern 
Sudan: the outbreak of Barbar El Fugara village (1996–1997). Microbes and Infection, 
4(14): 1439-1447. 
El Safi S. H., Abdel-Haleem A., Hammad A., El-Basha I., Omer A., Kareem H.G., Boelaert 
M., Chance M. and Hommel M. (2003). Field evaluation of latex agglutination test for 
detecting urinary antigens in visceral leishmaniasis in Sudan. Eastern Mediterranean 
Health Journal, 9(4): 844-855. 
Eltoum I. A., Zijlstra E. E., Ali M. S., Ghalib H. W., Satti M. M., Eltoum B. and El Hassan 
A. M. (1992). Congenital kala-azar and leishmaniasis in the placenta. Am J Trop Med 
Hyg. 1992 Jan;46(1):57-62. 
Fears M. B. and Pope V. (2001). Syphilis Fast Latex Agglutination Test, a Rapid 
Confirmatory Test. Clinic. and Diag. Lab. Immuno. 8(4): 841-842. 
Gari-Toussaint M., Leliévre A., Marty P., Le Fichoux Y. (1994). Contribution of serological 
tests to the diagnosis of visceral leishmaniasis in patients infected with the human 
immunodeficiency virus. Trans R Soc Trop Med Hyg., 88(3):301-302. 
Glew R. H., Saha A. K., Das S. and Remaley A. T.  (1988). Biochemistry of Leishmania 
Species. Microbiological Reviews, 52: 412. 
Górski S. and Wiercińska-Drapało A. (2009). [Visceral leishmaniasis as a threat for non-
endemic countries]. Wiad Parazytol., 55(3):195-200. 
Grandien M.,  Pettersson C., Svensson L. and Uhnoo I. (1987). Latex agglutination test for 
adenovirus diagnosis in diarrheal disease. J. of Med. Viro., 23(4): 311 - 316 
Hailu A. (1990). Pre- and post-treatment antibody levels in visceral leishmaniasis. Trans R 
Soc Trop Med Hyg., 84(5):673-675. 
Hamza, Y. O., Abdalla, R. E., Ahmed, M. A. M., Abdel Wahab, S. M., Omer, A., Abdelnur, 
O. M. and El Hassan, A. M. (1976). Northward spread of visceral leishmaniasis in the 
Sudan. Trans R Soc Trop Med Hyg., 89:266. 
Hang V. T., Nguyet N. M., Trung D. T., Tricou V., Yoksan S., Dung N. M., Van Ngoc T., 
Hien T. T., Farrar J., Wills B. and Simmons C. P. (2009). Diagnostic Accuracy of NS1 
ELISA and Lateral Flow Rapid Tests for Dengue Sensitivity, Specificity and 
Relationship to Viraemia and Antibody Responses PLoS Negl Trop Dis., 3(1): 360.  
Hashim F. A. and El Hassan A. M. (1994). Tinea versicolor and visceral leishmaniasis. Int J 
Dermatol., 33: 258-259. 
Hashim F. A., Ahmed A. E., El Hassan A. M., Ghalib H. W., El Safi S. H.and el Hag I. A. 
(1994). An outbreak of acute Kala-azar in a nomadic tribe in western Sudan: features 
Leishmania donovani of the disease in a previously non-immune population. Trans R Soc 
Trop Med Hyg.,  88: 431-432. 
Hatam G. R., Ghatee M. A., Hossini S. M., Sarkari B. (2009). Improvement of the newly 
developed latex agglutination test (Katex) for diagnosis of visceral lieshmaniasis. J Clin 
Lab Anal., 23(4):202-205. 
Ho M., Siongok T. K., Lyerly W. H., Smith D. H. (1982). Prevalence and disease spectrum 
in a new focus of visceral leishmaniasis in Kenya. Trans R Soc Trop Med Hyg., 
76(6):741-746. 
Hockmeyer W. T., Kager P. A., Rees P. H., Hendricks. L. D. (1981). The culture of 
Leishmania donovani in Schneider's insect medium: its value in the diagnosis and 
management of patients with visceral leishmaniasis. Trans R Soc Trop Med Hyg., 75(6): 
861-863. 
Hommel M., Kien Truong T. and Bidwell D. E. (1976). Immuno-enzymatic technic 
(E.L.I.S.A.) applied to the serological diagnosis of human candidiasis and aspergillosis. 
Preliminary results. Nouv Presse Med., 5(41): 2789-2791.  
Hommel M., Attar Z., Fargeas C., Dourado C., Monsigny M., Mayer R. and Chance M. L. 
(1997). The direct agglutination test: a non-specific test specific for the diagnosis of 
visceral leishmaniasis? Ann. of trop. med. and parasitol., 91(7):795-802. 
Hoogstraal H. and Heyeneman, D. (1969). Leishmaniasis in the Sudan. Am J Trop Med Hyg., 
18: 1091-1210  
Hopwood V. ,  Johnson E. M.,  Cornish J. M.,  Foot A. B.,  Evans E. G., Warnock D. W. 
(1995). Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis 
of invasive aspergillosis. J Clin Pathol, 48:210-213  
Houghton R. L., Petrescu M., Benson D. R., Skeiky Y. A., Scalone A., Badaró R., Reed S. G. 
and Gradoni L. (1998). A cloned antigen (recombinant K39) of Leishmania chagasi 
diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients 
and a prognostic indicator for monitoring patients undergoing drug therapy. J Infect Dis., 
177(5):1339-1344. 
Houghton R. L., Stevens Y. Y., Hjerrild K., Guderian J., Okamoto M., Kabir M., Reed S. G., 
Leiby D. A., Morrow W. W., Lorca M. and Raychaudhuri S. (2009). Lateral Flow 
Immunoassay for Diagnosis of Trypanosoma cruzi Infection with High Correlation to the 
Radioimmunoprecipitation Assay. Clinic. & Vacc. Immunol., 16(4):515-520. 
Ibrahim M. E., Evans D. A., Theander T. G., El Hassan A. M. and Kharazmi A. (1995). 
Diversity among Leishmania isolates from the Sudan: isoenzyme homogeneity of L. 
donovani versus heterogeneity of L. major. Trans R Soc Trop Med Hyg., 89:366-369. 
Ihalamulla, Rajapaksa and Karunaweera. (2005). Microculture for the isolation of 
Leishmania parasites from cutaneous lesions -- Sri Lankan experience. Ann. of Trop. 
Med. and Parasitol., 99(6):571-575. 
Irmak H., Buzgan T., Evirgen O., Akdeniz H., Demiroz A. P., Abdoel T. H., Smits H. L.. 
(2004). Use of the Brucella IgM and IgG flow assays in the serodiagnosis of human 
brucellosis in an area endemic for brucellosis. Am J Trop Med Hyg., 70(6):688-694. 
Jensen A. T. R., Gasim S., Moller T., Ismail A., Gaagar A., Kemp M., El Hassan A. M., 
Kharazami A., Alce T. M., Smith D. F. and Theander, T. G. (1999). Serodiagnosis of 
infection: assessment of enzyme-linked immunosorbent assay using recombinant L. 
donovani gene B protein and a peptide sequence of  L. donovani GBP. Trans R Soc Trop 
Med Hyg.,  93: 157-160. 
Jüttner C., Rodríguez Sánchez M., Rollán Landeras E., Slappendel R. J. and Fragío Arnold 
C. (2001). Evaluation of the potential causes of epistaxis in dogs with natural visceral 
leishmaniasis. Vet Rec., 149(6):176-179. 
Kaklikkaya N., Akdogan R. A., Ozgur O., Uzun D. Y., Cobanoglu U., Dinc U., Gungor E., 
Dabanca P. A., Arslan M., Aydin F. and Erturk M. (2006). Evaluation of a new rapid 
lateral flow chromatography test for the diagnosis of Helicobacter pylori. Saudi Med J., 
27(6):799-803. 
Kar, K. (1995). Serodiagnosis of leishmaniasis. Crit. Rev. Microbiol. 21:123-152 
Khyriem A. B., Sujatha S., Das A. K., Parija S. C. (2003). Comparison of latex agglutination 
and co-agglutination for the diagnosis and prognosis of cryptococcal meningitis. Indian J 
Med Microbiol, 21:252-256. 
Kirk, R. ( 1939). Studies in leishmaniasis in the Anglo-Egyptian Sudan. Part I. Epidemiology 
and general considerations. Trans R Soc Trop Med Hyg., 32: 533-544. 
Kirk R. and Lewis D. J. (1955). Studies on leishmaniasis in the Anglo-Egyptian Sudan. XI. 
Phlebotomus in relation to leishmaniasis in the Sudan. Trans R Soc Trop Med Hyg.,  
49:229-240. 
Kirk, R. (1956). Studies in leismaniasis in Anglo-Egyptian Sudan. XII. Attempts to find a 
reservoir host. Trans R Soc Trop Med Hyg.,  50: 169-177.  
Klaus S. and Frankenburg S. (1999). Cutaneous leishmaniasis in the Middle East. Clin 
Dermatol., 17(2):137-141. 
Kohanteb J., Ardehali S. M. and Rezai H. R. (1987). Detection of Leishmania donovani 
soluble antigen and antibody in the urine of visceral leishmaniasis patients. Trans R Soc 
Trop Med Hyg., 81(4):578-580. 
Kordofani Y. M., Nour Y. M., El Hassan A. M. and Shalayel M .F. (2001). Post kala azar 
dermal leishmaniasis in Sudan.  East Mediterr Health J., 7(6):1061-1064. 
Kreutzer R. D., Yemma J. J., Grogl M., Tesh R. B. and Martin T. I. (1994). Evidence of 
Sexual Reproduction in the Protozoan Parasite Leishmania. Am. J. Trop. Med. Hyg., 
51(3): 301-307 
Kuru T., Jirata D., Genetu A., Barr S., Mengistu Y., Aseffa A. and Gedamu L. (2007). 
Leishmania aethiopica: identification and characterization of cathepsin L-like cysteine 
protease genes. Exp Parasitol., 115(3):283-290. 
Lachaud L., Chabbert E., Dubessay P., Reynes J., Lamothe J. and Bastien P. (2001). 
Comparison of various sample preparation methods for PCR diagnosis of visceral 
leishmaniasis using peripheral blood. J Clin Microbiol., 39(2):613-617. 
le Fichoux Y., Quaranta J. F., Aufeuvre J. P., Lelievre A., Marty P., Suffia I., Rousseau D. 
and Kubar J. (1999). Occurrence of Leishmania infantum parasitemia in asymptomatic 
blood donors living in an area of endemicity in southern France. J Clin Microbiol., 
37(6):1953-1957. 
Lewis D. J. (1971). Phlebotomid sandflies. Bull World Health Organ., 44(4):535-551.  
Livni N., Abramowitz A., Londner M., Okon E. and Morag A. (1983). Immunoperoxidase 
method of identification of Leishmania in routinely prepared histological sections. 
Virchows Arch A Pathol Anat Histopathol., 401(2):147-151. 
Maalej I. A., Chenik M., Louzir H., Ben Salah A., Bahloul C., Amri F., Dellagi K. (2003). 
Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania 
antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am J Trop Med 
Hyg., 68(3):312-320. 
Malaei S., Mohebali M., Akhoundi B. and Zarei Z. (2006). Evaluation of latex agglutination 
test (Katex) for the detection of urinary antigens in 
human visceral leishmaniasis. J Tehran Un Med Sci., 4:101–108. 
Marfurt J., Nasereddin A., Niederwieser I., Jaffe C.L., Beck H.P. and Felger I. (2003). 
Identification and differentiation of Leishmania species in clinical samples by PCR 
amplification of the miniexon sequence and subsequent restriction fragment length 
polymorphism analysis. J Clin Microbiol, 41: 3147-3153. 
Martin-Sanchez J., Lopez-Lopez M. C., Acedo-Sanchez C., Castro-Fajardo J. J., Pineda J. A. 
and Morillas-Marquez F. (2001). Diagnosis of infections with Leishmania infantum using 
PCR-ELISA. Parasitology., 122(6):607-615. 
Mauricio I. L., Howard M. K., Stothard J. R., Miles M. A. (1999). Genomic diversity in the 
Leishmania donovani complex. Parasitology, 119(3):237-246. 
Mittal V., Bhatia R. and Sehgal S. (1991). Serodiagnosis of Indian kala-azar: evaluation of 
IFA, ELISA and CIEP tests. J Commun Dis., 23(2):131-134. 
Medrano F. J., Rey C., Leal M., Cañavate C., Rubio A., Sánchez-Quijano A., Alvar J. and 
Lissen E. (1998). Dynamics of serum cytokines in patients with visceral leishmaniasis 
and HIV-1 co-infection. Clin Exp Immunol., 114(3):403-407. 
Meredith S. E., Kroon N. C., Sondorp E., Seaman J., Goris M. G., van Ingen C. W., Oosting 
H., Schoone G. J., Terpstra W. J. and Oskam L.  (1995). Leish-KIT, a stable direct 
agglutination test based on freeze dried antigen for the serodiagnosis of visceral 
leishmaniasis. J Clin Microbiol., 33: 1742-1745. 
Mettler M., Grimm F., Capelli G., Camp H. and Deplazes P. (2005). Evaluation of enzyme-
linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests 
(immunochromatographic-dipstick and gel tests) for serological diagnosis of 
symptomatic and asymptomatic Leishmania infections in dogs. J Clin Microbiol., 
43(11):5515-5519. 
Minodier P., Piarroux R., Gambarelli F. and Dumon H. (1997). Rapid identification of 
causative species in patients with Old World leishmaniasis. J Clin Microbiol., 
35(10):2551-2555. 
Moody A. H. and El Safi S. H. (1996). A latex agglutination test for the serodiagnosis of 
visceral leishmaniasis in Sudan. Trans R Soc Trop Med Hyg.,  90: 522.  
Morales M. A., Chicharro C., Ares M., Canavate C., Barker D. C. and Alvar J. (2001). 
Molecular tracking of infections by Leishmania infantum. Trans. R. Soc. Trop. Med. 
Hyg., 95:104-107. 
Murray H. W. (2004). Treatment of visceral leishmaniasis in 2004. Am J Trop Med Hyg., 
71(6):787-94 
Nakamura M., Ohshima H. and Kondo T. (1992). Aggregation behavior of antibody-carrying 
latex particles. J. of Colloid and Interface Science, 154(2): 393-399.  
Namba A., Yaginuma Y.  and Musha T. (1991). Determination of the Agglutination 
Reactions Using Power Spectral Analysis of the Depolarized Light Intensity Fluctuations 
Scattered from Magnetic Particles. Jpn. J. Appl. Phys., 30: 1901-1905.   
NandLal S., VikramK M., AjitK N. and GhanshyamK V. (2009). The rK39 
immunochromatic dipstick testing: A study for K39 seroprevalence in dogs and human 
leishmaniasis patients for possible animal reservoir of cutaneous and visceral 
leishmaniasis in endemic focus of Satluj river valley of Himachal Pradesh (India). Indian 
Journal of Dermatology, Venereology and Leprology, 75(1): 52-55. 
Neave S. H. M. (1904). Leishmania donovani in the Sudan. BMJ, i: 1252 
Nyakundi P. M., Muigai R., Were J. B., Oster C. N., Gachihi G. S. and Kirigi G. (1988). 
Congenital visceral leishmaniasis: case report. Trans R Soc Trop Med Hyg., 82(4):564. 
Okong’o-Odera E.A., Kurtzhals J. A. L., Hey, A. S. and Kharazmi, A. (1995). Measurement 
of serum antibodies against native gp63 distinguishes between ongoing and previous L. 
donoani infection. APMIS, 101: 642-646. 
Oliveira A. G., Galati E., Fernandes C., Dorval M. and Brazil R. P. (2008). Seasonal 
variation of Lutzomyia longipalpis in endemic area of visceral leishmaniasis, Campo 
Grande, state of Mato Grosso do Sul, Brazil. Acta Tropica, 105(1): 55-61. 
Oliveira E., Pedras M. J., de Assis I. E. and Rabello A.Improvement of direct agglutination 
test (DAT) for laboratory diagnosis of visceral leishmaniasis in Brazil. (2009). Trans R 
Soc Trop Med Hyg., 103(12):1279-1281. 
Oskam L., Nieuwenhuijs J. L. and Hailu A. (1999). Evaluation of the direct agglutination test 
(DAT) using freeze-dried antigen for the detection of anti-Leishmania antibodies in 
stored sera from various patient groups in Ethiopia. Trans R Soc Trop Med Hyg., 
93(3):275-277. 
Osman O. F., Kager P. A., Zijlstra E. E., El Hassan A. M. and Oskam L. (1997a). Use of 
PCR on lymph-node samples as test of cure in visceral leishmaniasis. Ann. of Trop. Med. 
and Parasit., 91: 845-850. 
Osman O. F., Oskam L., Zijlstra E. E., Kroon N. C. M., Schoone G. J, Khalil E. A., El 
Hassan A. M. and Kager P. A. (1997b). Evaluation of PCR for diagnosis of visceral 
lieshmaniasis.  J Clin Microbiol., 35(10): 2454-2457. 
Osman O. F., Oskam L., Zijlstra E. E., El Hassan A. M., El Naeim D. A. and Kager P. A. 
(1998). Use of the polymerase chain reaction to assess the success of visceral 
leishmaniasis treatment. Trans R Soc Trop Med Hyg., 92(4):397-400. 
Oumeish O. Y. (1999). Cutaneous leishmaniasis: a historical perspective. 
Clin Dermatol., 17(3):249-254. 
Ozerdem D., Eroglu F., Genc A., Demirkazik M., Koltas I. S. (2009). Comparison of 
microscopic examination, rK39, and PCR for visceral leishmaniasis diagnosis in Turkey. 
Parasitol Res 106:197–200 
Pastoor R., Hatta M., Abdoel T. H., Smits H. L. (2008). Simple, rapid, and affordable point-
of-care test for the serodiagnosis of typhoid fever. Diagn Microbiol Infect Dis., 
61(2):129-134.  
Pearson R. and Sousa A. (1996). Clinical spectrum of leishmaniasis. Clin Infect Dis., 22:1–
13. 
Perea W. A., Ancelle T., Moren A., Nagelkerke M. and Sondorp E. (1991). Visceral 
leishmaniasis in southern Sudan. Trans R Soc Trop Med Hyg., 85:48-53. 
Piarroux R., Gambarelli F., Dumon H., Fontes M., Dunan S., Mary C., Toga B. and Quilici 
M. (1994). Comparison of PCR with direct examination of bone marrow aspiration, 
myeloculture, and serology for diagnosis of visceral Leishmaniasis in 
immunocompromised patients. J Clin Microbiol. 32(3):746-749. 
Pintado V., Martín-Rabadán P., Rivera M. L., Moreno S. and Bouza E. (2001). Visceral 
leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected 
patients. A comparative study. Medicine (Baltimore), 80(1):54-73. 
Pourzand C. and Cerutti P. (1993). Genotypic mutation analysis by RFLP/PCR. Mutat Res., 
288(1):113-121. 
Prasad L. S. and Sen S. (1996). Migration of Leishmania donovani amastigotes in the 
cerebrospinal fluid. Am J Trop Med Hyg., 55(6):652-654. 
Qu, J. Q., L. Zhong, M. Masoom-Yasinzai, M. Abdur-Rab, H. S. Aksu, S. G. Reed, K. P. 
Chang and A. Gilman-Sachs. (1994). Serodiagnosis of Asian leishmaniasis with a 
recombinant antigen from the repetitive domain of a Leishmania kinesin. Trans. R. Soc. 
Trop. Med. Hyg. 88:543–545. 
Raj S. V., Ghosh A., Dole V. S., Madhubala R., Myler P. J. and Sturat K. D. (1999). 
Serodiagnosis of leishmaniasis with recombinant ORFF antigen. Am. J. Trop. Med. Hyg., 
61: 482-487. 
Rajasekariah G. R., Ryan J. R., Hillier S. R., Yi L. P., Stiteler J. M., Cui L., Smithyman A. 
M. and Martin S.K. (2001) Optimisation of an ELISA for the serodiagnosis of visceral 
leishmaniasis using in vitro derived promastigote antigens. J. of Immunological Methods, 
252(1): 105-119. 
Reus M., García B., Vázquez V., Morales D., Fuster M. and Sola J. (2005). Visceral 
leishmaniasis: diagnosis by ultrasound-guided fine needle aspiration of an axillary node. 
Br J Radiol., 78(926):158-160. 
Riera C., Fisa R., Lopez P., Ribera E., Carrió J., Falcó V., Molina I., Gállego M. and Portús 
M. (2004). Evaluation of a latex agglutination test (KAtex) for detection of Leishmania 
antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and 
post-treatment follow-up. Eur J Clin Microbiol Infect Dis., 23(12):899-904. 
Rijal S., Boelaert M., Regmi S., Karki B. M., Jacquet D., Singh R., Chance M. L., Chappuis 
F., Hommel M., Desjeux P., Van der Stuyft P., Le Ray D. and Koirala S. (2004). 
Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar 
in eastern Nepal. Trop Med Int Health., 9(6):724-729. 
Rioux J. A., Lanotte G., Serres E., Pratlong F., Bastien P. and Perieres J. (1990). Taxonomy 
of Leishmania. Use of isoenzvmes. Suegestions for a new classification. Ann. de Parasit., 
Hum. et Comp., 65: 111 - 125. 
Ritmeijer K., Melaku Y., Mueller M., Kipngetich S., O'keeffe C. and Davidson R. N. (2006). 
Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral 
leishmaniasis. Am. J. Trop Med. Hyg., 74(1):76-80. 
Robert R., Mahaza C., Bernard C., Buffard C., Senet J. M. (1990). Evaluation of a new 
bicolored latex agglutination test for immunological diagnosis of hepatic amoebiasis. J. 
Clin. Microbiol., 28(6):1422-1424. 
Romero H. D., Silva L., Silva-Vergara M. L., Rodrigues V., Costa R. T., Guimarães S. F., 
Alecrim W., Moraes-Souza H. and Prata A. (2009). Comparative Study of Serologic 
Tests for the Diagnosis of Asymptomatic Visceral Leishmaniasis in an Endemic Area. 
Am. J. Trop. Med. Hyg., 81(1): 27-33 
Rosenzweig D., Smith D., Opperdoes F., Stern S., Olafson R. W., Zilberstein D. (2008). 
Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J., 
22(2):590-602. 
Rouf M. A., Rahman M. E., Islam M. N., Islam M. N., Ferdous N. N. and Hossain M. A. 
(2009). Sensitivity, specificity and predictive values of immunochromatographic strip test 
in diagnosis of childhood kala-azar. Mymensingh Med J., 18(1 Suppl):S1-5. 
Saghrouni F., Gaïed-Meksi S., Fathallah A., Amri F., Ach H., Guizani I. and Ben Saïd M. 
(2009). Immunochromatographic rK39 strip test in the serodiagnosis of visceral 
leishmaniasis in Tunisia. Trans R Soc Trop Med Hyg., 103(12):1273-1278 
Sah S. P., Prasad R. and Raj G. A. (2005). Fine needle aspiration of lymphadenopathy in 
visceral leishmaniasis. Acta Cytol., 49(3):286-290. 
Sarkari B., Chance M. and Hommel M. (2002). Antigenuria in visceral leishmaniasis: 
detection and partial characterization of a carbohydrate antigen. Acta Tropica 82: 339-
348. 
Sati, M. H. (1958). Kala-azar in the Sudan and tropical Africa. Proceeding of the Sixth 
International Congress on Tropical Medicine and Malaria, Lisbone, September 5-13, vol. 
3, pp. 646-657  
Sati, M. H. (1982). Changing epidemiology of leishmaniasis in the Sudan. Informal meeting 
on the chemotherapy of visceral leishmaniasis, Nairobi. Geneva: World Health 
Organization, ref. TDR/VISC/CHEMLEISH/82/WP/2. 
Schallig H. D., Schoone G. J., Kroon C. C., Hailu A., Chappuis F. and Veeken H. (2001). 
Development and application of 'simple' diagnostic tools for visceral leishmaniasis. Med 
Microbiol Immunol., 190(1-2):69-71. 
Schallig, H. D. F. H., Canto-Cavalheiro M., da Silva E. S. (2002). Evaluation of the direct 
agglutination test (DAT) and the rK39 dipstick tests for the serodiagnosis of visceral 
leishmaniasis. Memórias do instituto Oswaldo Cruz, 97: 1015-1018. 
Schnur L. F., Zuckerman A. (1977). Leishmanial excreted factor (EF) serotypes in Sudan, 
Kenya and Ethiopia. Ann Trop Med Parasitol., 71(3):273-294. 
Schnur L. F., Chance M. L., Ebert F., Thomas S. C. and Peters W. (1981). The biochemical 
and serological taxonomy of visceralizing Leishmania. Ann. of Trop. Med. and Parasit., 
75: 131 - 144. 
Seaman J., Mercer A. J., Sondorp H. E. and Herwaldt B. L. (1996). Epidemic visceral 
leishmaniasis in southern Sudan: treatment of severly debilitated patients under wartime 
conditions and with limited resources. Annual of International Medicine, 124: 664-672. 
Sehgal S. C., Vijayachari P., Sugunan A. P. and Umapathi T. (2003). Field application of 
Lepto lateral flow for rapid diagnosis of leptospirosis. J Med Microbiol 52: 897-901.  
Shamsuzzaman A., Mahmud C., Akhter S., Musa A. and Hossain A. (2007). LD Bodies 
From Blood Buffy Coat: an Easy Approach for Definitive Diagnosis of Visceral 
Leishmaniasis. Bangladesh J Med Microbiol,  1(2): 43-47. 
Sharma U., Singh S. (2008). Insect vectors of Leishmania: distribution, physiology and their 
control. J Vector Borne Dis., 45(4):255-272. 
Sharma N. L., Mahajan V. K., Negi A. K., Verma G. K. (2009). The rK39 immunochromatic 
dipstick testing: A study for K39 seroprevalence in dogs and human leishmaniasis 
patients for possible animal reservoir of coetaneous and visceral leishmaniasis in endemic 
focus of Satluj river valley of Himachal Pradesh (India). Indian J Dermatol Venereol 
Leprol, 75:52-55. 
Shreffler W. G., Burns J.M. Jr, Badaró R, Ghalib H.W., Button L.L., McMaster W.R., Reed 
S.G. (1993). Antibody responses of visceral leishmaniasis patients to gp63, a major 
surface glycoprotein of Leishmania species. J Infect Dis., 167(2): 426-430. 
Siddig M., Ghalib H., Shillington D. C. and Petersen E. A. (1988). Visceral leishmaniasis in 
the Sudan: comparative parasitological methods of diagnosis. Trans R Soc Trop Med 
Hyg., 82(1):66-68. 
Siddig M., Ghalib H. W., Shillington D. C., Petersen E. A. and Khidir S. (1990). Visceral 
leishmaniasis in Sudan. Trop. and Geog. Med., 42: 107 - 112. 
Silva E. S., Schoone G. J., Gontijo C. M., Brazil R. P., Pacheco R. S. and Schallig H. D. 
(2005). Application of direct agglutination test (DAT) and fast agglutination screening 
test (FAST) for sero-diagnosis of visceral leishmaniasis in endemic area of Minas Gerais, 
Brazil. Kinetoplastid Biol Dis., 14(4):4-10. 
Singh N., Ramesh V. and Arora V. K. (1998). Nodular post-kala-azar dermal leishmaniasis: a 
distinct histopathological entity. J Cutan Pathol, 25:95-99.   
Singh, S., A. Gilman-Sachs, K.-P. Chang, and S. G. Reed. (1995). Diagnostic and prognostic 
value of k39 recombinant antigen in Indian leishmaniasis. J. Parasitol., 81:1000–1003. 
Singh S., Kumari V. and Singh N. (2002). Predicting kala-azar disease manifestations in 
asymptomatic patients with latent Leishmania donovani infection by detection of 
antibody against recombinant K39 antigen. Clin Diagn Lab Immunol, 9(3):568-572.  
Sixl W., Sebek Z., Reinthaler F. and Mascher F. (1987). Investigations of wild animals as 
Leishmania reservoir in south Sudan. J. of Hyg., Epidem., Micro. and Immuno., 31: 483-
485. 
Sixl W., Sixl B., Abdel Nabi O. and Sebek, Z. (1989). Contribution to the problems of the 
diagnostics of leishmaniasis in South-Sudan. Geographic Medicine, 5: 189-203. 
Slinger R., Milk R., Gaboury I. and Diaz-Mitoma F. (2004). Evaluation of the QuickLab 
RSV Test, a New Rapid Lateral-Flow Immunoassay for Detection of Respiratory 
Syncytial Virus Antigen. J. Clin. Microbiol., 42(8): 3731-3733. 
Smits H. L., Van Der Hoorn M. A., Goris M. G., Gussenhoven G. C., Yersin C., Sakasi D., 
Rerpstra W. J. And Hartskeerl R. A. (2000). Simple latex agglutination assay for the 
rapid serodiagnosis of human leptospirosis. J Clin Microbiol., 38: 1272-1265. 
Smits H. L., Eapen C. K.,  Sugathan S., Kuriakose M.,  Gasem M. H., Yersin C., Sakasi D., 
Pujinto B., Vestering M., Abdoel T. H. and Gussenhoven G. C. (2001). Lateral flow 
assay for the rapid serodiagnosis of human leptospirosis. Clin Diagn Lab Immunol., 8: 
166-169. 
Smits H. L., Chee H. D., Eapen C. K.,  Kuriakose M.,  Sugathan S., Gasem M. H., Yersin C., 
Sakasi D., Lai-a-Fat R. F. M., Hartskeerl , Liesdek B., Abdoel T. H.,  Goris M. G. and 
Gussenhoven G. C.  (2003). Latex based rapid and easy assay for human leptospirosis in 
a single test format. Trop Med Int Health., 6: 114-118. 
Sohma K., Kinoshita Y., Morishita S., Fujino R. and Saito T. (1995). A novel magnetic 
particle agglutination in microtiter plates for rapid detection of human t-lymphotropic 
virus type1 antibody. J Clin Lab Anal., 9(1):59-62. 
Soto M., Requena J. M., Quijada L. and Alonso C. (1998). Multicomponent chimeric antigen 
for sero-diagnosis of canine visceral leishmaniasis. J. Clin. Microbiol., 36: 58-63. 
Stephenson R. W. (1940). An epidemic of Kala-azar in the Upper Nile Province of the 
Anglo-Egyptian Sudan. Ann. of Trop. Med. & Parasitol., 43: 175-179. 
Sundar S., Singh V. P., Sharma S., Makharia M. K. and Murray H. W. (1997). Response to 
interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. J. of Inf. 
Dis., 176: 1117–1119. 
Sundar S., Reed S. G., Singh V. P., Kumar P. C. and Murray H. W. (1998). Rapid accurate 
field diagnosis of Indian visceral leishmaniasis. Lancet., 21(351)(9102):563-565. 
Sundar S. and Rai M. (2002). Laboratory Diagnosis of Visceral Leishmaniasis. Clin Diagn 
Lab Immunol., 9(5): 951–958. 
Sundar S., Agrawal S., Pai K., Chance M. and Hommel M. (2005). Detection of leishmanial 
antigen in the urine patients with visceral leishmaniasis by a latex agglutination test. Am J 
Trop Med Hyg., 73(2): 269-271. 
Thakur C. P. (2000). Socioeconomics of visceral leishmaniasis in Bihar (India). Tran. R. Soc. 
Trop. Med. Hyg. 94:156-157.  
Van Peenen P. F. D. and Reid T. P. (1963). Leishmaniasis in the Sudan Republic. VI. An 
outbreak of Kala-azar in the Khor Falus Area, Upper Nile Province. J Trop Med Hyg., 
66: 244-252.  
Veeken H. (1999). Manual for the Diagnosis and Treatment of Visceral Leishmaniasis (Kala-
Azar) under Field Conditions. Médecins sans Frontières, Amsterdam, The Netherlands.  
Veeken H., Ritmeijer K., Seaman J. and Davidson R. (2003). Comparison of an rK39 
dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of 
kala-azar in Sudan. Trop. Med. and  inter. Health, 8(2): 164–167. 
Veress B., Omer A., Satir A. A. and El Hassan A. M. (1977). Morphology of the spleen and 
lymph nodes in fatal visceral leishmaniasis. Immunology,33(5):605-610. 
Vilaplana C., Blanco S., Domínguez J., Giménez M. and Ausina V. (2004). Non invasive 
method for diagnosis of visceral leishmaniasis by latex agglutination test for detection of 
antigens in urine samples. J Clin Microbiol., 42(4): 1853-1854. 
Volpini A. C., Passos V. M., Oliveira GC and Romanha A. J. (2004). PCR-RFLP to identify 
Leishmania (Viannia) braziliensis and L. (Leishmania) amazonensis causing American 
cutaneous leishmaniasis. Acta Trop., 90(1):31-37. 
Webb B. J. and Baker C. J. (1980). Commercial latex agglutination test for rapid diagnosis of 
group B streptococcal infection in infants. J. Clin. Microbiol., 12(3): 442-444. 
Wijeyaratne P. M., Arsenault L. K. and Murphy C. J. (1994). Endemic disease and 
development: the leishmaniases. Acta Trop., 56(4):349-364. 
Wirth D. F., Rogers W. O., Barker R., Dourado H., Suesebang L. and Albuquerque B. 
(1989). Leishmaniasis and malaria: DNA probes for diagnosis and epidemiological 
analysis. Ann N Y Acad Sci., 569:183-192. 
Workman S., Wells S. K., Pau C. P., Owen S. M., Dong X. F., LaBorde R. and Granade T. C. 
(2009). Rapid detection of HIV-1 p24 antigen using magnetic immuno-chromatography 
(MICT). J Virol Methods., 160(1-2):14-21.  
Wortmann G., Sweeney C., Houng H. S., Aronson N., Stiteler J., Jackson J. and Ockenhouse 
C. (2001). Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain reaction. 
Am J Trop Med Hyg., 65(5):583-587. 
Yadav T. P., Gupta H., Satteya U., Kumar R. and Mittal V. (1989). Congenital kala-azar. Ann 
Trop Med Parasitol., 83(5):535-537. 
Youssef M. Y,, Eissa M. M., and Mansoury S. T. (1997). Evidence of sexual reproduction in 
the protozoan parasite Leishmania of the Old World. J Egypt Soc Parasitol, 27(3):651-
657. 
Yu Z., Jin M. , Xu X. , Zhang R. , Zhou H. , Hu Q. , Wu H., Qin B., Tan Y. , and Chen H. 
(2006). Development of a Specific Latex Agglutination Test Based on a Recombinant 
Hemagglutinin Protein to Detect Antibodies to H5 Avian Influenza Viruses. Avian 
Diseases 50(2):264-268. 
Zijlstra E. E., Ali M. S., El Hassan A. M., El Toum I. A., Satti M., Ghalib H. W., Kager P. A. 
(1991). Direct agglutination test for diagnosis and sero-epidemiological survey of kala-
azar in the Sudan. Trans R Soc Trop Med Hyg., 85(4):474-476. 
Zijlstra E. E., Ali S., El Hassan A. M., El Tom I. A, Satti M., Ghalib  H. W. and Kager P. A. 
(1992). Comparative parasitological methods and direct agglutination test in the 
diagnosis of Kala-azar. Trans R Soc Trop Med Hyg., 86: 505-507.  
Zijlstra E. E., El Hassan A. M., Ismael A. and Ghalib H. W. (1994). Endemic Kala-azar in 
eastern Sudan: A longitudinal study on the incidence of clinical and subclinical infection 
and post Kala-azar dermal leishmaniasis. Am J Trop Med Hyg., 51(6): 826-836. 
Zijlstra E. E., Osman O. F., Hofland H. W., Oskam L., Ghalib H. W., El Hassan A. M., 
Kager P. A., Meredith S. E. (1997). The direct agglutination test for diagnosis of visceral 
leishmaniasis under field conditions in Sudan: comparison of aqueous and freeze-dried 
antigens. Trans R Soc Trop Med Hyg., 91(6):671-673. 
Zijlstra E. E., Daifalla N. S., Kager P. A., Khalil E. A. G., Reed S. G. and Ghalib H. W.. 
(1998). rK39 enzyme-linked immunosorbent assay for diagnosis of leishmania donovani 
infection. Clin Diagn Lab Immunol., 5(5): 717-720. 
Zijlstra E. E., Khalil E. A., Reed S. G., Ghalib H. W., Kager P. A. And El Hassan A. M. 
(2000). Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and 
differential diagnosis. Brit J Dermatol, 143:136-143. 
Zijlstra E. E. and El Hassan A. M. (2001). Leishmaniasis in Sudan. 3.Visceral leishmaniasis. 
Trans R Soc Trop Med Hyg., 95 ( S1): 27-58.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
